151
GENETICALLY MODIFIED MYOGLOBIN AS A MIMIC FOR HEME ENZYMES by SUBHASH CHAND Presented to the Faculty of the Graduate School of The University of Texas at Arlington in Partial Fulfillment of the Requirements for the Degree of DOCTOR OF PHILOSOPHY THE UNIVERSITY OF TEXAS AT ARLINGTON May 2013

Genetically Modified Myoglobin As A Mimic For Heme Enzymes

  • Upload
    vocong

  • View
    222

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

GENETICALLY MODIFIED MYOGLOBIN AS A MIMIC FOR HEME ENZYMES

by

SUBHASH CHAND

Presented to the Faculty of the Graduate School of

The University of Texas at Arlington in Partial Fulfillment

of the Requirements

for the Degree of

DOCTOR OF PHILOSOPHY

THE UNIVERSITY OF TEXAS AT ARLINGTON

May 2013

Page 2: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

Copyright © by Subhash Chand 2013

All Rights Reserved

Page 3: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

iii

ACKNOWLEDGEMENTS

I would like to take this opportunity to express my deepest gratitude to my advisor, Dr.

Roshan Perera, for his excellent guidance, support, understanding, patience, inspiration and

constant encouragement which have been instrumental in providing my graduate research

every success. I would also like to thank the members of my advisory committee, Dr.

Subhrangsu S. Mandal and Dr. Jongyun Heo, for their many invaluable opinions towards my

research. I would like to express my deep gratitude to Dr. Krishnan Rajeshwar, and Dr. Daniel

W. Armstrong for being extremely generous with their precious advice and collaborative

research and guidance that kept my research focused. In addition, I would like to thank Dr. Brad

Pierce and Dr. Kayunta Johnson-Winters for allowing me to use the various facilities for my

research and assisting me to learn some very significant techniques.

I am very much indebted to Dr. Brian Edwards, Dr. Norma Tacconi and Dr. Muhammed

Yousufuddin, for sharing their copious knowledge and helping me with many of the

instrumentation parts used in my research. I would like to express my utmost thankfulness to

the Department of Chemistry and Biochemistry and the Graduate school of The University of

Texas at Arlington for supporting my graduate studies here.

It was a pleasure to share my doctoral studies with lab-mates like Dr. Sriparna Ray, Dr.

Sridev Mohapatra, Leticia Loredo, Yanbo Zhang, Sriyani Liyanage, Nam Tran, Brian Stamos,

Tuan Phan, Chris Wilson, Jimmy Saing and Buuh Yousuf. I owe my sincere appreciation to Dr.

Sriparna Ray for her continuous efforts in checking thesis, which required many hours.

Last but not least, I would like to thank my family, my father, Mr. Keshaw Prasad Yadav,

my mother, Mrs. Urmila Devi, my brothers Shrikant Yadav, Sandeep Yadav, Shashikant Yadav

and Manish Yadav, my cousins Mr. Ram Chander Yadav and Sunil Yadav and my friends of

UTA and beyond - Prasad, Piyush, Bibhu, Chetan, Swanand, Megha, Prashant, Aakash, Amit,

Page 4: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

iv

Soumyava, Saket, Kirti, Karthik, Irene, Valay, Vaishali, Ajoy, Mrunmayi, Prudhvi and Ajinkya for

their support during my stay in UTA as well as in my research.

I would like to make a special mention of my uncle, Mr. Harendra Kumar Yadav who

has showered me with unconditional love and endless support necessary to succeed in life.

April 16, 2013

Page 5: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

v

ABSTRACT

GENETICALLY MODIFIED MYOGLOBIN AS A MIMIC FOR HEME ENZYMES

Subhash Chand, PhD

The University of Texas at Arlington, 2013

Supervising Professor: Roshan Perera

This study addresses the mechanistic relationships between formation of reactive

oxygen species (ROS) and their catalytic oxidation functions in oxygenation and peroxygenation

reactions in heme enzymes. Even though both cytochrome P450s (CYP P450s) and

peroxidases have different catalytic activities, the involvement of common ROS (Compound 0

and Compound I) have been proposed. Therefore, to understand the generation and activation

of peroxide to form ROS, genetically-engineered myoglobin (Mb) mutants were created by

incorporating redox-sensitive 3-amino-L-tyrosine (NH2Tyr) or L-3, 4-dihydroxyphenylalanine

(DOPA) into its active site. Distal His 64 replaced with redox amino acids mutant Mb showed

excellent turnover rates for thioanisole and benzaldehyde oxidation, compared to the wild-type

protein. A 9-fold and 81-fold increase in activity, respectively, was observed in the presence of

hydrogen peroxide (H2O2). The presence of a redox unnatural amino acid in the active site

enhances the rate of compound I formation and stabilizes it to form one extra H-bond as

compared to the wild type (WT) Mb. This increased oxidation activity in mutants offer insights

into the role of the distal active site residues which are involved in acid-base catalysis and distal

charge relay “pull” effect in peroxide activation and formation of ROS in heme proteins.

Page 6: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

vi

Furthermore, cyclic voltammetry (CV) and atomic force microscopy (AFM) were used to

investigate the importance of active site orientation of an immobilized protein for direct electron

transfer (DET) and electrocatalysis. While the bioconjugated wild-type myoglobin (WT Mb) was

immobilized on the modified gold electrode surface in a random multilayered fashion, the Ser 3

replaced with NH2Tyr in Mb mutant, was immobilized via a Diels-Alder reaction specific to the

NH2Tyr residue to form a homogeneous monolayer. Electrochemical calculations for the

number of surface exposed redox-sensitive molecules on the electrode surface (Γ) and

heterogeneous rate constant for DET were 1.29 × 10–10

mol cm–2

; 2.3 sec–1

for the WT Mb and

1.54 × 10–10

mol cm–2

; 1.3 sec–1

for the S3NH2Tyr Mb mutant, respectively. Electro-catalytic

conversion of thioanisole to sulfoxide products showed similar turnover frequencies (TOF)

around 1.9 × 103 sec

–1 (with 87% conversion) for the WT Mb, and 1.5 × 10

3 sec

–1 for the mutant

Ser 3-amino-L-tyrosine (S3NH2Tyr) Mb (with 81% conversion). These results indicate that site-

directed single monolayer immobilization affords almost the same number of surface exposed

Mb active sites as the random multilayer immobilization strategy, though the latter contains a

greater number of protein molecules on the electrode surface. The microarray concept

development provides novelty to study protein-protein interactions, drug discovery, and

biomedical and proteomic research.

Another aspect of this research was that the importance and significance of electron

rich functional groups on the electronic nature of heme center had been extensively explored. It

has been found that the axial His attached to the heme center plays a decisive role in dictating

the electron cloud near the heme center. When the axial heme is replaced by a residue with an

electron rich functional group like pNO2 L-Phenyl alanine (pNO2Phe), the electron density was

higher near the heme center. The oxidation state of the metal center and the nature of the

ligand play important role in the determination of back-bonding and direction of charge transfer.

Page 7: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

vii

TABLE OF CONTENTS

ACKNOWLEDGEMENTS.............................................................................................................iii

ABSTRACT...................................................................................................................................v

LIST OF ILLUSTRATIONS..........................................................................................................xii

LIST OF FIGURES......................................................................................................................xii

LIST OF TABLES........................................................................................................................xv

LIST OF SCHEMES....................................................................................................................xvi

PREFACE..................................................................................................................................xvii

Chapter Page

1. INTRODUCTION……………………………………………………………………………1

1.1 Heme proteins……………………………………………………………………1

1.1.1 Myoglobin ……………………………………………………………. 5

1.2 Incorporation of unnatural (noncanonical) amino acids into proteins……… 7

1.3 Direct electron transfer and bioelectrocatalysis……………..…………….... 10

1.4 Dissertation overview ............................................................................…..12

2. MECHANISTIC INSIGHTS AND IMPROVED OXIDATION ACTIVITY USING

GENETICALLY-ENGINEERED MYOGLOBIN........................................................... 14

2.1 Introduction..................................................................................................14

2.2 Experimental section...................................................................................17

2.2.1 Chemicals....................................................................................17

2.2.2 Preparation of WT Mb and H64NH2Tyr Mb mutant

construct...…………………………………………………………...17

2.2.3 WT Mb and H64NH2Tyr Mb protein purification………….………18

2.2.4 WT Mb and H64NH2Tyr Mb protein analysis.....………….………18

2.2.5 Spectroscopy………………………………………………..……….20

Page 8: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

viii

2.2.6 Preparation of oxyferrous complexes……………………………..20

2.2.7 Effect of hydrogen peroxide………………………………………...21

2.2.8 Catalytic Sulfoxidation of Thioanisole and Oxidation

of Benzaldehyde………………………………………………………21

2.2.9 Electrochemical Instrumentation…………………………………...21

2.3 Results and Discussion…………………………………………………………25

2.3.1 Genetic design rationale and characterization…………………...25

2.3.2 Catalytic activity……………………………………………………...28

2.3.3 ABTS Peroxidase assay…………………………………………….29

2.3.4 Electrochemical characterization…………………………………..30

2.3.5 Ligand binding study of WT and H64NH2Tyr Mb mutant…….….33

2.3.6 Mechanistic insights………………………………….......…………36

2.4 Conclusions…………………………………………………………………...…37

3. INTRODUCTION OF PEROXIDASE ACTIVITY IN MYOGLOBIN BY INCORPORATING AN UNNATURAL AMINO ACID AT THE DISTAL HISTIDINE POSITION..............................................................................................38

3.1 Introduction……………….………………………………………………….…38

3.2 Experimental procedure..............................................................................40

3.2.1 Chemicals………………………………………..............................40

3.2.2 Preparation of WT Mb and H64DOPA Mb mutant

constructs.......................................................................................40

3.2.3 WT Mb and H64DOPA Mb protein purification and analysis ......40

3.2.4 Spectroscopy...…………………………………………..................42

3.2.5 Effect of hydrogen peroxide........................................................42

3.2.6 Preparation of oxyferrous complex..............................................42

3.2.7 Preparation of CO, NO, cyanide, and azide adduct

samples..........................................................................................42

Page 9: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

ix

3.2.8 Catalytic sulfoxidation of thioanisole and oxidation

of benzaldehyde..........................................................................43

3.2.9 Electrochemical instrumentation................................................43

3.3 Results and discussion.............................................................................43

3.3.1 UV-visible spectroscopic characterization of WT and

H64DOPA mutant…....................................................................43

3.3.2 Deoxyferrous and oxyferrous species of WT Mb and

H64DOPA Mb............................................................................46

3.3.3 CO, NO, cyanide, and azide adducts of WT and

H64DOPA Mb..........................................................................47

3.3.4 Redox potentials of WT and mutant Mb....................................49

3.3.5 Thioanisole sulfoxidation and benzaldehyde oxidation..............51

3.4 Conclusion..............................................................................................55

4. FAVOURABLE BINDING SITE ORIENTATION IN MYOGLOBIN FOR DIRECT ELECTRON TRANSFER, ELECTROCATALYSIS, AND MICROARRAY INVESTIGATION...........................................................................56 4.1 Introduction…………................................................................................56

4.2 Experimental Section……........................................................................60

4.2.1 Chemicals................................................................................60

4.2.2 Preparation of WT Mb and S3NH2Tyr mutant Mb construct......60

4.2.3 WT Mb and S3NH2Tyr Mb protein purification..........................60

4.2.4 UV-vis spectroscopy................................................................63

4.2.5 AFM measurements…………………………..............................63

4.2.6 Ligands adduct formation...............................................…......64

4.2.7 Preparation of microarray........................................................64

4.2.8 Electrochemical instrumentation and procedures………...........65

4.2.9 Electrode modification procédures…………………………… …65

4.2.9.1 Au/L-Cys/WT Mb………………………………………..65

4.2.9.2 Au/L-Cys/TEGDA/ S3NH2Tyr Mb…….………...........66

Page 10: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

x

4.2.9.3 Electrocatalysis..........................................................66

4.3. Results and discussion……………………………………………….....……..66

4.3.1 Monolayer vs. multilayer covalent immobilization of Mb on Au………………………………………………………….....….66 4.3.2 Electrochemical characterization................................................73

4.3.3 Catalytic studies.........................................................................82

4.3.4 Microarray studies......................................................................83

4.3.4.1 Preparation of functional protein microarrays...........................83

4.3.5 Ligand binding studies................................................................88

4.4. Conclusion………………………………………………………………………88

5. ELECTRONIC NATURE INVESTIGATION OF HEME CENTER BY

MODIFYING PROXIMAL AND DISTAL BINDING SITE ENVIRONMENT OF

SPERM WHALE MYOGLOBIN WITH ELECTRON RICH RESIDUES.......................90

5.1 Introduction.................................................................................................90

5.2 Experimental Section..................................................................................92

5.2.1 Chemicals...................................................................................92

5.2.2 Preparation of WT, H64pNO2Phe and H93pNO2Phe

Mb mutant constructs.................................................................92

5.2.3 WT, H64pNO2Phe and H93pNO2Phe Mb purification and

analysis..........................................................................................93

5.2.4 Electronic absorption spectroscopy............................................94

5.2.5 Preparation of deoxyferrous Mb..................................................96

5.2.6 Preparation of oxyferrous complex.............................................96

5.2.7 CO and NO complex preparation................................................96

5.2.8 Azide and cyanide complex preparation.....................................96

5.3 Results and discussion.............................................................................96

Page 11: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

xi

5.3.1 Ferrous-CO, ferrous-NO and ferrous O2 complexes of WT

and H64pNO2Phe and H93pNO2Phe mutants of myoglobin.........98

5.3.2 Ferric-cyanide and ferric-azide complexes of WT

and H64pNO2Phe and H93pNO2Phe mutants of Mb...................105

5.4 Conclusion.................................................................................................110

REFERENCES..........................................................................................................................111

BIOGRAPHICAL INFORMATION.............................................................................................128

Page 12: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

xii

LIST OF ILLUSTRATIONS

Figures Page

1.1 Structures of heme a and heme b........................................................................................2 1.2 Structures of naturally occurring iron porphyrines…............................................................3

1.3 Overall structure of sperm whale Mb.......…………………..........................................….....6

1.4 A general method for genetically encoding unnatural amino acids in live cells…................8

1.5 The list of unnatural amino acids that have been introduced to the genetic codes of E. coli, yeast and mammalian cells.......................................................................9

1.6 Schematic representations of bioelectrocatalysis involving direct electron transfer in an enzyme........…..............................................................................…….......12

2.1 Mechanistic pathway for generation of the highly reactive Compound I from the ferric resting form in heme-proteins………………………………………………………..15

2.2 Schematic representation of the oxyferrous complex of WT Mb..…………………………..17

2.3 Coomassie-stained SDS-PAGE analysis of expression of WT Mb and H64NH2Tyr Mb.............................................…………………………………….………....….19

2.4 The mass spectrum (MALDI-TOF) of the H64NH2Tyr Mb protein…………………...……20

2.5 GC analysis of oxidation products of thioanisole and benzaldehyde ………………...…….24

2.6 Electronic absorption spectra of the H64NH2Tyr Mb.........................................................27

2.7 Effect of H2O2 on WT ans mutant Mb…………………………………………………………..28

2.8 Deoxyferrous and oxyferrous spectra of WT and mutant Mb…………………………….....28

2.9 Differential pulse voltammetry (DPV) of WT and mutant Mb in presence and absence of H2O2.…..........................................................................................................32

2.10 Characterization of WT and H64NH2 Mb ligand complexes…......................................35

2.11 Mechanism of oxidation of 3-amino-L-tyrosine which releases 2-electrons and two protons to produce quinone product in the presence of an oxidant……….……37

3.1 Schematic representation of the formation of compound I and compound II

Page 13: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

xiii

in Mb and HRP..…............................................................................................................39

3.2 Analysis of WT and H64DOPA mutant Mb by SDS-PAGE and MALDI-TOF.........……....41

3.3 High-valent heme complexes of WT and H64DOPA Mb..................................................44

3.4 Stability of WT and H64DOPA Mb in presence of H2O2...........................................…………….......45

3.5 Deoxyferrous and oxyferrous spectra of WT and H64DOPA mutant Mb………….…....…46

3.6 Study of WT and H64DOPA Mb ligand complexes....…………………………….……........50

3.7 Reduction potential of WT and H64DOPA Mb in presence and absence of H2O2 at pH 7.0 and at pH 10.0................................................................................…....50

3.8 Gas-chromatography data and MS data of thioanisol and benzaldehyde oxidation with WT and H64DOPA....................................................................................52

3.9 Proposed acid-base catalytic mechanism for compound I formation in H64DOPA mutant Mb in presence of H2O2 .................................................................55

4.1 Graphical representation of WT and S3NH2Tyr mutant Mb attachment on modified gold electrodes................................................................................................................59

4.2 Coomassie-stained sodium SDS-PAGE analysis of S3NH2Tyr Mb and WT Mb..............61

4.3 Electrospray ionization-time of flight-mass spectrometry (ESI-TOF-MS) analysis of the incorporation of S3NH2Tyr into S3(TAG) Mb …………………..…….....…62

4.4 Tapping mode AFM topographic images for chemically modified Au surface of immobilized S3NH2Tyr Mb mutant and with WT Mb...................................................72

4.5 CV response of L-Cys-modified, WT Mb and S3NH2Tyr Mb mutant immobilized gold electrode in nitrogen-purged 100 mM phosphate buffer…...………………….….....73

4.6 CV and peak current response of WT and mutant Mb.....................................…...........74

4.7 Plot of peak potentials vs pH for WT Mb and S3NH2Tyr Mb..........................................78

4.8 Comparision of immobilized Mb with hemin on modified gold electrode.........................81

4.9 A microarray of five proteins on a single slide displays...................................................85

4.10 Spectroscopic characterization of high spin, low spin and ligand complexes of WT and mutant Mb..........................................................………....................…........87

5.1 Showing structure of heme b and heme c.......................................................................91

5.2 Schematic representations of WT and mutants Mb.........................................................92

5.3 Coomassie-stained SDS-PAGE analysis of expression of WT Mb, H64pNO2Phe and H93pNO2Phe mutants Mb.......................................................................................94

Page 14: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

xiv

5.4 Characterization of ferric WT and mutants Mb.................................................................97

5.5 Deoxyferrous electronic absorption spectra of WT, H64pNO2Phe and H93pNO2Phe mutant Mb..................................................................................................98

5.6 The heme carbonyl complex showing dπ–pπ* backbonding…........................................99

5.7 Showing presence of electron rich functional group (NO2

-) at distal position……………...99

5.8 Comparative studies of carbonyl complexes of WT, H64pNO2Phe, and H93pNO2Phe ……………………………………......………………………………..…...102

5.9 Comparative studies of NO complexes of WT, H64pNO2Phe, And H93pNO2Phe...........................................................................................................108

.

5.10 Characterization of oxyferrous complexes of WT, H64pNO2Phe, and H93pNO2Phe Mb.................................................................................................104 5.11 Proposed structure of Fe (II) O2, Fe (II) CO and Fe (II) NO..........................................105 5.12 Comparative studies of cyanide complexes of WT, H64pNO2Phe, and H93pNO2Phe Mb....................................................................................................107 5.13 Characterization of azide oxyferrous complexes of WT, H64pNO2Phe, and H93pNO2Phe Mb....................................................................................................108 5.14 Two canonical forms of azide bound to heme iron of WT Mb and H64pNO2Phe Mb mutant.............................................................................................109

5.15 Two canonical forms of cyanide bound to heme iron of WT Mb and H64pNO2Phe Mb mutant ............................................................................................109

Page 15: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

xv

LIST OF TABLES

Table Page

1.1 Biological functions of heme proteins…………………………………………………….........…4

2.1 Rate of sulfoxidation of thioanisole and benzaldehyde oxidation by WT Mb and mutant H64NH2Tyr Mb...………………………………………………………..……………29

2.2 ABTS oxidation reaction assays of Mb and its mutant in the presence of 5 mM H2O2. Kinetic values are based on the average of at least 2 determinations……..….30

2.3 Reduction potentials were measured at pH 7.0 and 10.0 in the absence and presence of 5 mM H2O2………………………………………………………………….….……33

3.1 Reduction potential of WT Mb, H64DOPA Mb mutant and DOPA only at pH 7.0 and pH 10.0 in presence and absence of H2O2 ……………...........…………………..………49

3.2 Rate of sulfoxidation of thioanisole and benzaldehyde oxidation by WT Mb and H64DOPA mutant Mb..………....……..…….………………………………………….....…..53

3.3 ABTS oxidation reaction assays of Mb and its H64 DOPA mutant Mb in the presence of 5 mM H2O2.......................................................................................................54

4.1 Comparison of heterogeneous electron transfer rates of myoglobin on gold electrodes…..77

4.2 Comparison of direct electrochemistry of Mb on various electrode systems………………..79

4.3 Electrocatalytic conversion of thioanisole to its oxidized form and turnover frequency (TOF) using bare, multilayered WT Mb-immobilized and monolayered S3NH2Tyr Mb……..82

5.1 The electronic absorption spectral features of the oxy, carbonyl, NO, cyanide and azide complexes with H64pNO2Phe Mb, H93pNO2Phe Mb mutants and WT Mb………….100

Page 16: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

xvi

LIST OF SCHEMES

Scheme Page

4.1 Schematic representation of Au electrode modification for monolayered immobilization of S3NH2Tyr Mb mutant on the Au surface; see text for details………...…..68

4.2 Schematic representation of multilayered WT Mb immobilization on the modified gold electrode surface using EDC catalyzed bioconjugation reaction...................................70

Page 17: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

xvii

PREFACE

This study “Genetically modified myoglobin as a mimic for heme enzymes” is submitted by

Subhash Chand to The University of Texas at Arlington for the degree of Doctor of Philosophy

(Ph.D.), and has the following kind contributions. Chapter 4 was published as “S. Ray, S.

Chand, Y. Zhang, S. Nussbaum, R. Krishnan, R. Perera, Immobilization of Myoglobin on the

Gold Electrode to Promote Direct Electron Transfer, Electrochimica. Acta. 2013, 99, 85-93”. In

this study Dr. Ray has carried out electrochemistry studies. Figures (4.1, 4.5, 4.6, 4.7, and 4.8)

and schemes (4.1 and 4.2) were kindly contributed by her. The microarrays studies in chapter 4

have been publisted as “B. Stamos, L. Loredo, S. Chand, T. Phan, Y. Zhang, S. Mohapatra, R.

Perera, Biosynthetic Approach for Functional Protein Microarrays, Anal. Biochem. 2012, 424,

114-23”.

Page 18: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

1

CHAPTER 1

INTRODUCTION

1.1 Heme proteins

Heme proteins are the big family of proteins and are widely distributed in nature. Some

of these proteins act as oxygen storage (e.g., myoglobin) and some as an oxygen carrier (e.g.,

hemoglobin). While other heme proteins play important roles either in mediating electron

transfers (e.g., Cyt b5, Cyt c), or in catalysis (e.g., cytochrome P450, peroxidase, and catalase)

(1, 2). Along with heme, many enzymes contain other cofactors such as molybdopterin, copper,

flavin, and iron-sulfur cluster (1, 2). In these proteins (e.g., flavocytochrome b2, flavocytochrome

c3, p-cresolmethyl hydroxylase, sulfite oxidase, fructose dehydrogenase, alcohol

dehydrogenase, and cytochrome c oxidase), charge transfer is the main function of heme

domain. Iron porphyrin prosthetic groups are the most common among all heme proteins (1-3).

Different varieties of porphyrins such as heme a, heme b, heme c, heme d, heme d1, heme

P460, heme o, siroheme, and chloroheme are present in heme proteins (Figures 1.1 and 1.2,

and Table 1.1). These porphyrins have a common basic skeleton, but due to substitution at

various positions, they differ in their structural details. In heme proteins, nitrogen from the

porphyrin ring occupy four coordination sites out of six of the heme iron, leaving only two

positions available for further ligand interactions which strongly influence the reactivity and

redox potential of the heme protein (1-3).

In many heme and globin enzymes, penta-coordinated heme iron is found (1, 3). In

globins, the proximal histidine (His) residue act as fifth ligand while axial heme position remains

open for O2 coordination, while the sixth coordination position is used for substrate binding in

some heme enzymes (1, 3). The redox potential of the heme center depends on the variety of

proximal ligands while distal ligands are responsible for the catalytic reaction in general (2, 3).

Page 19: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

2

The spin state of the heme center is governed by the nature of axial ligands (1, 2). If a

water molecule is present as the sixth ligand, the center is in a high spin state, while presence

of carbon monoxide (CO), nitric oxide (NO), O2 azide (N3–),

and cyanide (CN

–) as the sixth

ligand makes it in a low spin state (2, 3).

Heme type b is the simplest form of all known hemes and contains methyl group at 1, 3,

5, and 8 positions. At the same time 6 and 7 positions have two propionate groups and also 2

and 4 positions have vinyl groups (1). Energetically favored orientation of heme is the coplanar

structure, where vinyl group and the aromatic heme plane have the capability to interact with the

amino acids scaffold in the proteins (1, 2).

Heme a Heme b

Figure1.1 Structures of heme a and heme b.

Page 20: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

3

Heme c Heme d

Heme d1 Heme o

Figure1.2 Structures of naturally occurring iron porphyrines.

Page 21: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

4

Table 1.1 Listing biological functions, type, axial ligation and oxidation state of heme proteins (2).

Protein family

Protein function Type of heme Axial ligation Oxidation/spin state

Cytochromes c Electron transfer c His Fe(II) (S = 0)

Fe(III) (S =1/2)

Mb Hemoglobins O2 storage

O2 transport

b

b

His

Deoxy Fe (II) (S = 2)

Oxy Fe(II) (S = 0)

Peroxidases A-H2+H2O2 → A+2H2O b His Fe(III) (S = 5/2)

Catalases H2O2+ H2O2 → O2 + 2H2O b Tyr Fe(III) (S = 5/2)

P450 proteins RH +2e– + 2H

+ + O2 → ROH + H2O b Cys Fe(III) (S = 5/2)

Cytochrome bo quinol

oxidases

O2 + 4 Fe(II)cyt c + 4e– + 4H

+ → 4

Fe(III)cyt c + 2H2O o His Fe(III) (S = 5/2)

Hydroxylamine

oxidoreductase H2O + NH2OH → NO2

– + 4e

– + 5H

+ P 460 His

Fe(III) (S = 5/2)

Or (S = 3/2)

Nitric reductases (cyt d1) 2H

+ + NO2

– + e

– → NO + 2H2O

4H+ + O2

– + 4e

– → 2H2O

d1 His

His+ Tyr

Fe(III) (S = 1/2)

Sulfate Reductase 8H+ + NO2

– + 6e

– → NH4

+ + 2H2O Siroheme Cys Fe(II) (S =1 or 2)

Page 22: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

5

1.1.1 Myoglobin

Myoglobin (Mb) is a relatively small heme protein (17 kDa) that is less affected by

environmental conditions when compared to most of the other heme proteins. Mb is a single-

chain globular protein of 153 amino acids, as found in the sperm whale, and serves as oxygen

storage (4, 5). It consists of eight separate right-handed α helices in its apoprotein (Figure 1.3).

Oxygen can bind at the distal site of proteins, directly to the iron atom of the heme. The axial

His (His 93) links protein to the heme center through a bond between the iron atom and the His

(2, 4). As shown in figure 1.2, a wide variety of amino acid residues are present near the binding

site of Mb. These residues play a critical role in determining the electronic nature of the heme

center and catalytic nature of the heme proteins (4-6). Studies shows that in Mb, the positions

such as 64, 68, and 93 are the most crucial residues (4). Due to its ability to prepare mixed

ligand complexes with different valences (ferric, ferrous, and ferryl species), Mb is often used as

a model to mimic other heme proteins such as cytochromes, peroxidases, catalases,

chloroperoxidases, and many more (5-10).

The role of the proximal ligand in controlling the reactivity and stabilizing the heme has

been a matter of interest for many years. In Mb, the role of proximal and distal His has been

assessed by replacing it with different residues (11-15) .

Mb is an oxygen storage heme protein; however, in presence of H2O2, it catalyzes a

variety of oxidative reactions such as sulfoxidation and epoxidation. Since Mb does not form a

stable Mb compound I in presence of H2O2, the rate of epoxidation and sulfoxidation are

significantly slow in Mb as compared to those of peroxidases (16-19). Watanabe and coworkers

have created mutations at 64, 43, and 29 positions of Mb, replacing respective amino acids with

Asp, His, and Trp, as well as with Leu and His in double mutants. They have been able to

introduce catalase monooxygenase and peroxidase activity in Mb by generating compound I in

different Mb mutants (16-27).

Page 23: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

6

Figure 1.3 Overall structure of sperm whale Mb. (A) WT Mb showing heme center and His at 64 and 93 positions and (B) schematic representation of binding site of WT Mb.

A

B

His 93

His 64

Heme center

Heme

Leu 29

Val 68

Ile 107 His 64

Leu 89 His 97

His 93

Ser 92

Phe 43

Page 24: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

7

Dawson and coworkers have created an H93G Mb cavity mutant and explored it as an

excellent structural model for His-ligated and other heme containing proteins (15, 28-32). They

have successfully compared and used Mb mutants as a model for the study of cytochrome f,

nitrite reductases, peroxidases, cytochrome P450, and many other heme proteins (15, 29, 33-

43). They have also extensively studied the ligand binding properties of heme proteins (6, 35,

43).

1.2 Incorporation of unnatural (noncanonical) amino acids into proteins

There are two strategies for the incorporation of noncanonical amino acids/unnatural

amino acids (UAA) into proteins: (1) site-specific and (2) residue-specific (44, 45). The site-

specific approach involves replacement of a single amino acid residue (Figure 1.4) while the

residue-specific method allows replacement of all or a fraction of one of the natural amino acids

by UAA (44-52). In the site-specific method, to deliver the analog in response to a stop or four-

bases codon, a heterologous tRNA/aminoacyl-tRNA synthetase pair is used (53). Amber codon

suppression in mammalian cells has been used to incorporate unnatural amino acids by using

the E. coli tRNA/aminoacyl-tRNA synthetase pair; none of the suppressor tRNA was charged by

any of the mammalian aminoacyl-tRNA synthetases (54). For the site-specific incorporation of

UAA, amber codon suppression is the most frequently used method (Figure 1.3) and to date

more than 50 UAA have been introduced in recombinant proteins using these methods (Figure

1.4) (44, 52). For the incorporation of structurally, chemically and spectroscopically amino acids,

Schultz and coworkers have produced orthogonal suppressor tRNA/aminoacyl-tRNA synthetase

pairs and used it to incorporate many UAA in recombinant proteins (55-60). By using both four

base codon and nonsense codon suppression, Dougherty and coworkers have successfully

incorporated two UAA into an ion channel protein (61-63). Four bases codons, commonly

known as frameshift suppression, have also been used for the site-specific insertion of UAA into

fluorophore proteins and in many more recombinant proteins (50, 63-65).

Page 25: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

8

Figure 1.4 A general method for genetically encoded unnatural amino acids in live cells.

Page 26: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

9

Figure 1.5 The list of unnatural amino acids that have been introduced to the genetic codes of E. coli, yeast, and mammalian cells.

Page 27: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

10

Furthermore, for the site-specific incorporation of UAA, analogous five bases codon and

reassignment of sense codons can also be used, but fidelity of the method is much lower than

that of anti-sense or frameshift suppression methods (66-68). It is possible in the genetic code

that one amino acid can be coded by more than one codon, as there are 61 codons for 20

natural amino acids; this makes the genetic code highly degenerate. In E.coli, many amino

acids are coded by more than one codon. Phe is coded by UUU and UUC. Only one tRNA has

been assigned for both codons. The tRNA uses base pairing and wobble interaction to decode

UUC and UUU, respectively. tRNA synthetases from different organisms have been used for

the reassignment of UUU into host E.coli. The discriminating capability of synthetases between

unnatural and natural amino acids plays a crucial role in the incorporation of UAA and yield of

recombinant proteins.

Similar to post-translational modification, chemical methods for protein modification are

equally important and they have been used to enhance the performance of therapeutic proteins

and labeling with fluorescent dyes (69, 70). Highly reactive Cys and Lys residues have been

most commonly used in the process of protein modifications (70).

1.3 Direct electron transfer and bioelectrocatalysis

Electrochemical methods are very useful in determining the redox properties of proteins

and kinetics of electron transfer (71). Electrochemistry can be used as a powerful tool in the

biocatalytic study of a protein and in biosensors and biofuel cell production (72). In general, to

facilitate the electron communication in between electrode and redox-sensitive protein, small

soluble mediators were used (72, 73). Due to the possibility of their unspecific side reaction,

these mediators lead to erroneous results; to overcome this problem, direct electron transfer

(DET) methods were developed. For the electron communication, the DET methods do not

require a mediator between the enzymes and the electrodes. These methods at times have

Page 28: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

11

their own limitation such as denaturation of protein upon adsorption on electrodes, which can be

solved by using different varieties of linkers and insulators.

The acceleration of the electrochemical reactions by a biological enzyme comes under

the realm of bioelectrocatalysis, and electrons can be transferred between an enzyme active

site and the electrode without any mediator. Electrodes for fuel cells and for the biosensors are

the two most common applications of bioelectrocatalysis. It was essential to achieve DET in

redox enzymes on solid electrode for its further development. In addition, to achieve the most

effective electron transfer, the importance of protein orientation on the solid electrode surface

has been investigated (71-73).

In principles, bioelectrocatalysis involves acceleration of the electrochemical reactions

by biological catalysis (72). Figure 1.6 indicates the involvement of the enzymes in direct

bioelectrocatalysis. The communication of electrons with the electrode was provided by enzyme

catalyzing redox reactions. Oxidation and reduction reactions are the two halves of redox

reactions and one of these half reactions can be substituted in bioelectrocatalysis (72).

Heme is among those prosthetic groups which can communicate directly with the

electrode. Heme can be used both in formation of the enzyme active center as well as for the

communication with the redox mediator, thereby leading to communication with the electrode.

This makes heme one of the most important constituents of direct bioelectrocatalysis systems

and hence heme proteins are frequently used in bioelectrocatalysis (74, 75).

Page 29: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

12

Figure 1.6 Schematic representations of bioelectrocatalysis involving direct electron transfer in an enzyme. One of the two coupled half-reactions is substituted by the electrochemical reaction.

1.4 Dissertation overview

Creation of genetically engineered Mb mutants by incorporating a non-cannonical

redox-active NH2Tyr into its active site for the mechanistic insight and oxidative activity has

been extensively explored in chapter 2. This study proposed the importance of the distal binding

site residues in acid-base catalysis and formation of reactive oxygen species (ROS) in heme

proteins.

In chapter 3, I reported the incorporation of another unnatural amino acid DOPA to a

specific position in the binding site of Mb. The mutant Mb protein could carry out the oxidation of

thioanisole and benzaldehyde and support the idea that the distal His is important for the

formation of compound I to exhibit peroxygenase activity in Mb.

In chapter 4, I reported monolayer and multilayer immobilization of Mb using two unique

immobilization techniques, onto a chemically-modified gold electrode surface. Further, using

Page 30: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

13

DET method bioelectrocatalysis of thioanisole oxidation was carried out successfully with both

the protein immobilized electrodes. The results described in chapter 4 suggest the importance

of proper orientation of recombinant heme proteins containing UAA in bioelectrocatalysis and

effective electron transfer as comparison to the random multilayered WT Mb case. I have also

analyzed the protein-protein interactions of five different proteins which have been covalently

attached onto a solid support. Functional protein microarray concept development was

confirmed by catalytic activity assay using spectroscopic characterization, which will be of huge

importance in the field of drug discovery, and biomedical and proteomic research.

In chapter 5, I have summarized the importance and significance of electron rich

residues on the electronic nature of heme center. I have observed that the axial His attached to

the heme center plays a more crucial role in dictating the electron cloud near the heme center

and hence in formation of reactive species. When axial heme residue was replaced by electron

rich residue like pNO2Phe, it contributed to higher energy and red shift of the spectra due to the

higher electron density near the heme center. This study also explored the oxidation state of the

metal center, the nature of the ligand, the type of residues near the heme center that play an

important role in determining of backbonding, the direction of charge transfer, and the possibility

of hydrogen bonding. I also underlined that the size of UAA residue plays a crucial role in the

stability of ligand adducts.

Overall in this study I have used Mb as a model for the heme protein to study their

monooxygenase and peroxidase activity. No prior studies were reported using mutant protein

that utilizes its UAA acid residue to immobilize site specifically onto the electrode surface. I also

explored the DET and bioelctrocatalysis and importance of the proper orientation of protein

using Mb mutants as a model for heme proteins. This study also offers a similar orientation

concept while dealing with the protein microarray problems. The Mb mutants have also been

used to explore the role and effect of different varieties of residues near the heme center and

their effect in ligand binding spectra.

Page 31: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

14

CHAPTER 2

MECHANISTIC INSIGHTS AND IMPROVED OXIDATION ACTIVITY USING GENETICALLY

ENGINEERED MYOGLOBIN

2.1 Introduction

Peroxidase enzymes couple substrate oxidation to H2O2 reduction (as generically

represented by Reaction 1). They are widely distributed throughout the plant and animal

kingdoms and are frequently isolated from bacteria, mold, and microorganisms (76-78). Their

main biological function is to act as antioxidants by protecting cells, tissues, and organs against

the oxidation of a variety of organic and inorganic compounds by H2O2, organic hydroperoxides,

peracids, or inorganic oxysalts, such as periodate or chlorate (79-85).

AH2 + H2O2 A + 2H2O (1)

Most heme-containing peroxidases (e.g., horseradish peroxidase, HRP) have a

proximal His and a polar distal pocket, with a non-ligated His as an H+ acceptor/donor and a

cationic arginine to stabilize developing negative charges during O-O bond cleavage.

Peroxidases transform the oxidizing power of H2O2 into high-valent, protein-bound oxidants. The

general peroxidase pathway (Figure 2.1) involves addition of H2O2 or other oxygen atom donors

([O]) to the ferric resting state (1) to form Compound I (5), a ferryl (FeIV

) radical species where

the π-cation radical is usually centered on the porphyrin (86). Compound I typically oxidizes

substrates by one electron to yield an organic radical and Compound II (6), a ferryl heme

complex (79, 87). Compound II then oxidizes another substrate molecule and returns to the

ferric state (1). A ferryl state-like peroxidase, Compound I, is thought to be the active species in

the catalytic cycle (88, 89). Involvement of a hydroperoxo-ferric intermediate (Compound 0) has

also been proposed (6, 82). Alternatively, addition of H2O2 to ferric-heme protein can generate

Compound 0 (4) via a peroxide “shunt” pathway. Heme-containing peroxidases such as HRP

Page 32: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

15

form Compound I from Compound 0 using distal catalytic arginine amino acids to “pull” the O-O

bond apart heterolytically.

Figure 2.1 Mechanistic pathway for generation of the highly reactive Compound I (5) from the ferric resting form (1) in heme-proteins.

Lacking this distal machinery, WT Mb undergoes nearly equal amounts of homo- and

heterolytic cleavage upon H2O2 addition. Compound II, the stable product of homolytic cleavage

of the O-O bond of (6), is the prime product of Mb but has no catalytic activity. Previous

research shows that site-directed mutagenesis is a versatile technique to change the functional

properties of Mb. Thus the distal His (H64) has been replaced by amino acids such as Ala, Ser,

Leu and Asp, and the corresponding effect on the activity of Mb has been probed (90). Recent

Page 33: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

16

reports evaluated the His93Gly (H93G) “cavity” mutant of Mb as a versatile scaffold for

modeling heme states (29, 35, 36). The difference in accessibility of the two sides of the heme

have frequently made it possible to prepare mixed ligand adducts in ferrous, ferric, as well as

ferryl, oxidation states with this mutant. In addition, the protection provided to the heme by the

protein environment allows for the preparation of stable oxyferrous and oxo-iron (IV) complexes

at near-ambient temperatures with sperm whale Mb. Similar studies have been carried out to

obtain spectroscopic characterization of homogeneous oxyferrous complexes of the cytochrome

P450 BM3 (CYP102) holoenzyme and heme domain (BMP) at –55 °C in presence of 70/30 (v/v)

glycerol/buffer cryosolvent (91).

Taking the above facts into account, I can effectively model the heme protein active site

using a natural probe. Here in this study, Mb mimic of peroxidase enzymes using unnatural

amino acids was used to characterize the active species in the catalytic cycle, investigate the

catalysis mechanism, and to model the heme protein active sites (44, 92). To this end, Mb, an

oxygen storage and carrier protein, was converted into a catalytically active peroxygenase using

a genetically incorporated redox-active NH2Tyr into its active site (Figure 2.2) (44, 93-95). The

mutant H64NH2Tyr Mb was then employed to investigate the structure-function relationship in

heme proteins (based on acid-base catalysis and distal charge relay effect).

A Mb mutant in which His 64 was replaced with NH2Tyr (H64NH2Tyr) showed high

turnover rates for thioanisole and benzaldehyde oxidation (9-fold and 81-fold), when compared

to WT, in the presence of H2O2. Our results indicate a possible situation where acid-base

catalysis of NH2Tyr coupled with distal “pull” effect via the hydrogen bonding network, play an

important mechanistic role to mimic peroxidase. Furthermore, peroxygenase activity of this

mutant exhibited remarkable stability against heme bleaching with the generation of active

catalytic species.

Page 34: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

17

Figure 2.2 Schematic representation of the oxyferrous complex of Mb. (A) binding site of WT Mb. (B) active site of H64NH2Tyr, (PDB number 1MBO).

2.2 Experimental procedure

2.2.1 Chemicals

The gases (O2 and N2) were purchased from Air Liquide USA while NH2Tyr, sodium

dithionite (Na2S2O4), thioanisole, benzaldehyde, 30% H2O2, and 2,2’-azino-bis(3-

ethylbenzothiazoline-6-sulphonic acid) (ABTS) were purchased from Sigma-Aldrich USA, and

used without any further purification. All chemicals were at least analytical grade.

2.2.2 Preparation of WT Mb and H64NH2Tyr Mb mutant constructs

The WT Mb expression constructs, H64NH2Tyr Mb gene expression vector and

aminoacyl tRNA synthetase (aatRNA S) plasmids were gifts from Dr. Peter Schultz (The

Scripps Research Institute, La Jolla, CA USA). The H64NH2Tyr Mb expression vector and tRNA

synthetase plasmid were co-transformed in DH10B E. coli bacteria cells. The double antibiotic

resistant colonies were picked, grown, and the cell stocks were stored at –80 °C prior to protein

expression and purification.

Page 35: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

18

2.2.3 WT Mb and H64NH2Tyr Mb protein purification

The H64NH2Tyr Mb was expressed in E. coli grown in glycerol minimal media (GMML)

containing 25% Luria Broth (LB) media and suitable antibiotics (ampicillin and tetracycline).

Both the WT Mb and mutated (H64NH2Tyr) Mb proteins were induced by adding 0.02%

arabinose to bacterial cultures when optical density at 600 nm (O.D600) was 0.5. Cells were

harvested by centrifugation at 13000 g and lysed in lysis buffer (Tris HCl buffer at pH 8.0) by

addition of RNase, Dnase, and lysozyme to the cell contents, followed by three freeze (liquid

N2) thaw (37 °C) cycles and 10 rounds of 40 sec sonications on ice. The crude lysate was

mixed thoroughly with Ni-NTA resin and the protein-bound nickel-nitrilotriacetic acid (Ni-NTA)

was collected in a column. Purified proteins were eluted from the column using an elute buffer

(300 mM NaCl, 250 mM imidazole, 50 mM phosphate buffer, pH 7.0). The purified WT Mb and

mutant proteins were stored at –80 °C until further use.

2.2.4 WT Mb and H64NH2Tyr Mb protein analysis

The sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis

were shown in figure 2.3. The mass of mutant H64NH2Tyr Mb protein was analyzed by matrix-

assisted laser desorption/ionization-time of flight (MALDI-TOF) and was observed to be 18397

Da, (Figure 2.4) which matched with the theoretically calculated mass.

Page 36: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

19

Figure 2.3 Coomassie-stained SDS-PAGE analysis of expression of WT Mb and H64NH2Tyr Mb. (A) Lane 1, Molecular weight standards as indicated in kiloDalton (kDa); Lane 2, expressed WT Mb; Lane 3, expressed H64NH2Tyr Mb, (B) Lane 1, Molecular weight standards as indicated in kDa; Lane 2, expressed H64NH2Tyr mutant Mb in the absence (–) of 1 mM NH2Tyr; Lane 3, expressed H64NH2Tyr Mb in the presence (+) of NH2Tyr. No Mb protein was found by SDS−PAGE analysis in the absence of NH2Tyr.

Page 37: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

20

Figure 2.4 The mass spectrum (MALDI-TOF) of the H64NH2Tyr Mb protein. A mass of 18397 Da matches the calculated mass for the Mb mutant. No WT Mb protein (predicted mass, 18356 Da) was observed.

2.2.5 Spectroscopy

UV-visible electronic absorption spectra of WT Mb and mutant Mb proteins were

acquired on a Varian Cary 50 Bio UV-visible spectrophotometer. The concentration of WT Mb

was determined using pyridine hemochromogen method (96) .

2.2.6 Preparation of oxyferrous complexes

The oxyferrous complexes were prepared in a chest freezer at –35 to –45 °C. The

protein sample was taken in 100 mM potassium phosphate buffer (pH 7.0) which contained

65% glycerol (v/v). The ferric protein was first degassed with N2 gas for 2 hr Then it was

reduced to a deoxyferrous species by addition of Na2S2O4 (20 mg/mL stock) under N2

Page 38: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

21

atmosphere in a sealed cuvette at 4 °C. Pre-cooled O2 gas was bubbled into the cuvette for 60

s and the UV-visible spectra were recorded (Figure 2.8) as indicated in the previous study (32).

2.2.7 Effect of H2O2

The effect of H2O2 on ferric proteins was observed in the presence of 5 mM H2O2. The

protein concentration was 5 μM and heme bleaching of proteins was observed at 20 °C (Figures

2.6 and 2.7).

2.2.8 Catalytic sulfoxidation of thioanisole and oxidation of benzaldehyde

In the total volume of 500 μL, 100 mM potassium phosphate buffer pH 7.0, the 5 μM

protein (WT Mb or H64NH2Tyr mutant Mb) was added. To that 1 mM substrate, either

thioanisole or benzaldehyde was added. To initiate the reaction, 5 mM H2O2 was added to a

final volume of 500 µL. The reaction mixture was incubated for 1 hr After incubation the organic

products were extracted in dichloromethane. The solvent was reduced and the organic products

were analyzed by gas chromatography-mass spectrometry (GC-MS) (Figure 2.5).

2.2.9 Electrochemical instrumentation

Differential pulse voltammetry (DPV) was carried out using a single-compartment,

three-electrode cell at 22 °C on a CHI720C electrochemical analyzer (CH Instruments, Austin,

TX). The working electrode was polycrystalline gold, the counter electrode was a platinum wire,

and the reference electrode was Ag/AgCl/3.5 M KCl (BAS, West Lafayette, IN). All potential

values below are reported with respect to the Ag/AgCl reference electrode. The working

electrode surface was first polished on microcloth with alumina slurry suspension (0.05 μm),

then sonicated in ethanol, and finally rinsed thoroughly with Milli-Q water. The electrolyte

solution was 0.1 M K2HPO4/KH2PO4 buffer at a pH of 7.0. The solutions were deoxygenated by

bubbling nitrogen prior to each experiment. The concentration of H2O2 used was 5 mM. The

Page 39: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

22

DPV measurements were recorded with pulse amplitude of 30 mV, step size set at 4 mV, pulse

width at 0.05 sec, and pulse period at 0.20 sec (Figure 2.9).

Page 40: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

23

Page 41: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

24

Figure 2.5 GC-MS analysis of oxidation products of thioanisole ans benzaldehyde. Conversion of thioanisole (a) to its sulfoxidation product (b) by 5 mM H2O2. (A), GC data of WT Mb; (B), GC data of H64NH2Tyr mutant Mb, (C), mass spectrum of thioanisole sulfoxide product, (D) mass spectrum of benzoic acid product, (E) and (F) show GC and MS data of oxidation of benzaldehyde (a) to benzoic acid (b) by 5 µM Mb and H2O2 for WT Mb and H64 H64NH2Tyr respectively. The reaction was carried out by adding 5 mM H2O2 to 5 µM WT or mutant Mb in 0.5 mL of 100 mM potassium phosphate buffer (pH 7.0) with 1 mM thioanisole or benzaldehyde at 25 °C.

Page 42: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

25

2.3 Results and Discussion

2.3.1 Genetic design rationale and characterization

In the heme-containing peroxidases, the generation of active Compound I species

depends on precise delivery of two protons at the distal oxygen of the peroxo-ferric intermediate

(4). Another essential feature is the presence of the distal His and the Arg in the active site

pocket of the peroxidases (8, 21, 97). In HRP, the distal Arg influences the distal His to react

with H2O2 and form the active Compound I through an acid-base mechanism. But in WT Mb, the

distal His is not affected by any other distal amino acid and cannot induce the formation of

Compound I efficiently. Therefore, I decided to incorporate a redox-sensitive NH2Tyr amino acid

in place of the distal His. In the presence of an oxidant (e.g., H2O2), the redox-active NH2Tyr

amino acid should be able to facilitate an oxidation reaction which releases two electrons and

two protons (Figure 2.2) as well as to induce the formation of Compound I. Therefore, I

expected the H64NH2Tyr mutant Mb to behave as a considerably more potent peroxygenase

catalyst due to the increased oxygenase activity around the heme environment.

To facilitate the de novo design of Mb with unique peroxidase functionality, I have

genetically encoded NH2Tyr into Mb, replacing His 64 with the amber nonsense codon TAG into

a pBAD expression vector, using a previously reported technique. The method includes the

genetic incorporation of non-canonical amino acids into proteins using orthogonal

tRNACUA/aminoacyl-tRNA synthetase pairs in bacteria. The expressed H64NH2Tyr Mb showed

were analyzed by SDS- PAGE (Figure 2.3). Mass spectral analysis (MALDI-TOF) showed a

parent ion mass of 18397 Da as expected for the H64NH2Tyr Mb mutant (Figure 2.4).

The electronic absorption spectra of purified H64NH2Tyr mutant displayed a sharp

Soret absorption peak at 410 nm (visible peaks around 539 nm, 579 nm and 624 nm),

consistent with the aquo-ferric complex. Surprisingly, addition of 5 mM H2O2 did not show

significant Soret shift (λmax = 410 nm) or heme-bleaching for the NH2Tyr mutant Mb (Figure 2.6).

Page 43: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

26

Figure 2.6 Electronic absorption spectra of the WT and mutant Mb. H64NH2Tyr Mb in the presence of 5 mM H2O2 (black solid line), in absence of H2O2 (blue dashed dot dot line) and WT Mb in the presence of 5 mM H2O2 (green dot line) and in absence of H2O2 (red dashed line). ε = Molar extinction coefficient.

However, there were isosbestic points in the spectra between the peaks in the

presence and absence of H2O2 with the mutant to indicate that a novel catalytic species had

been generated (Figure 2.6). As expected, the WT protein formed Compound II (the Soret

around 418 nm) with 5 mM H2O2 with significant heme loss within the first 15 min of the reaction

(Figure 2.7) (98).

Page 44: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

27

Figure 2.7 Effect of H2O2 on WT and mutant Mb. Absorbance changes monitored over a 30 min period at λmax = 418 nm for WT Mb (blue dashed dot dot line) and λmax = 410 nm for H64NH2Tyr mutant Mb (black solid line) in the presence of 5 mM H2O2 and control (red dashed line). The spectra were measured in 100 mM potassium phosphate buffer, pH 7.0 at 20 °C with 10 μM protein.

In addition, the oxyferrous and deoxyferrous complexes of the H64NH2Tyr mutant and

the WT Mb were prepared at –35 to –45 °C. The UV-visible spectra were recorded (Figure 2.8),

which exhibited that the inherent characteristics of the native heme were intact in both the WT

and the H64NH2Tyr mutant Mb.

Page 45: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

28

Figure 2.8 Deoxyferrous and oxyferrous spectra of WT and mutant Mb. The spectra of WT Mb deoxyferrous (blue dashed line), H64NH2Tyr Mb deoxyferrous (red dashed line), WT Mb oxyferrous (green dotted line) and H64NH2Tyr Mb oxyferrous (black solid line) species. The spectra were taken at –35 to –45 °C and the samples were examined in 60% glycerol, 100mM phosphate buffer at pH 7.0.

2.3.2 Catalytic activity

A number of substrates including thioanisole and benzaldehyde were successfully

oxidized to their products by the mutant. Sulfoxidation of thioanisole (Reaction 2) and oxidation

of benzaldehyde to benzoic acid (Reaction 3) by 5mM H2O2 for H64NH2Tyr mutant Mb showed

2.4 min–1

(9-fold higher activity compared to WT Mb) and 4.05 min–1

(81-fold higher activity than

WT Mb) turnover rates, respectively (Table 2.1). However, under the same conditions WT Mb

shows only 0.25 min–1

for sulfoxidation and 0.05 min–1

for the oxidation of benzaldehyde.

Page 46: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

29

Table 2.1 Rate of sulfoxidation of thioanisole (Reaction 2) and benzaldehyde oxidation

(Reaction 3) by WT Mb and mutant H64NH2Tyr Mb. Kinetic values are based on the average of at least 2 determinations and the unit for rate is turnover per min.

Protein Km (µM) Vmax (µM min–1

)

WT Mb 19.3 25.6 [a]

H64NH2Tyr Mb 50.25 69.93

[a] This value is in agreement with data previously reported (26)

2.3.3 ABTS peroxidase assay

2,2’-Azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) or ABTS has often been used

to estimate the reaction kinetics of enzymes like peroxidases. In the presence of H2O2 and

peroxidase.enzyme, it is converted to its radical cation. This blue colored radical cation is

utilized to indirectly identify the formation of the ferryl radical species in peroxidases (26, 99). In

order to detect the development of the reactive species in the WT and mutant H64NH2Tyr Mb,

the ABTS peroxidases assay was performed. The results are contained in Table 2.2. The

Page 47: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

30

reaction mixture contained 1 µM protein, 5 mM H2O2 and ABTS. The concentration of ABTS

was varied from 0.02 mM to 2 mM (97, 100, 101).

Table 2.2 Peroxidase assay of WT and mutant Mb with ABTS in presence of H2O2. ABTS

oxidation reaction assays of Mb and its mutant in the presence of 5 mM H2O2. Kinetic values are based on the average of at least 2 determinations and the unit for rate is turnover per min.

Reaction has been done at pH 7.0 and at 20 °C.

Protein Km (µM) Vmax (µM min–1

)

WT Mb 19.3 [a]

25.6 [a]

H64NH2Tyr Mb 50.25 69.93

[a] This value is in consistent with data previously reported (99).

The ABTS radical cation formation was monitored at 730 nm. The Km and Vmax values

were calculated from Linewearver-Burk plots. The detection of the ABTS radical cation, in turn,

corroborated the peroxidase activity of the WT and mutant H64NH2Tyr Mb (101).

2.3.4 Electrochemical characterization

To understand the effect of the distal proton and electron delivery network via NH2Tyr

residue in Mb, we measured the reduction potentials (E°) for Mb and its mutant in the presence

of H2O2 at pH 7 as well as at pH 10 (Table 2.3) using differential pulse voltammetry (DPV). The

E° values confirmed that the primary amine and hydroxyl groups in NH2Tyr amino acid influence

the electronic nature of the iron at the heme active site. In the presence of H2O2 at pH 7.0, the

mutant (–360 mV) exhibited a 40 mV shift from the WT Mb (–320 mV), which is more than the

difference observed (27 mV) at pH 10.0 (Figure 2.9 and Table 2.3). Since a single hydrogen

bond results in a 25-60 mV change in the E° values (102, 103), the observed potential

Page 48: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

31

difference between the mutant and the WT Mb is consistent with the presence of an additional

hydrogen bond for H64NH2Tyr mutant than the His-64 in WT Mb.

Page 49: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

32

32

Figure 2.9 DPV of WT and mutant Mb in presence and absence of H2O2. The DPV response of 5 µM WT and mutant H64NH2Tyr Mb in nitrogen saturated 100 mM phosphate buffer and 10 mM KCl solutions (A and C: at pH 7.0; B and D: at pH 10.0) in absence (A and B) and in presence (C and D) of H2O2 at room temperature conditions. Pulse amplitude = 30 mV, step size = 4 mV, pulse duration = 0.05 sec and pulse period = 0.20 sec.

Page 50: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

33

Table 2.3 Reduction potential of WT and mutant Mb. Reduction potentials were measured at pH 7.0 and 10.0 in the absence and presence of 5 mM H2O2. All reduction potentials are reported with respect to Ag/AgCl (3.5 M KCl) reference electrode.

Reduction Potential, E (V)

Protein

Without H2O2

With 5 mM H2O2

pH 7.0

pH 10.0

pH 7.0

pH 10.0

WT Mb

–0.232

–0.256

–0.260

–0.292

H64NH2Tyr Mb

–0.244

–0.256

–0.352

–0.320

A possible reason for the 27 mV shift with H2O2 at pH 10 (than the 40 mV at pH 7) is

that the redox-sensitive amino acid (NH2Tyr) can be more easily oxidized (pKa is ~10 for

hydroxyl group in NH2Tyr) to o-imino-quinone by releasing two electrons and two protons, which

would preferentially promote the formation of the heme high valent (ferryl) species in the Mb

mutant.

2.3.5 Ligand binding study of WT and H64NH2Tyr Mb mutant adducts

The replacement of distal His with redox residue like NH2Tyr gave us an important

insight of the nature of electronic absorption spectra. From Figure 3.6, I observed that after

addition of neutral ligands such as CO, NO and O2 to WT and mutant Mb, the Soret became

sharper at respective places. The CO adduct is linear and both of its π orbitals are empty,

which allows dπ-π orbitals to overlap in a perpendicular direction resulting in greater

overlapping. It provides the perfect condition for π backbonding, while under similar conditions

NO and O2 adducts have less π backbonding because they have one or two electrons in their

orbitals (104). Since mutant Mb form an extra hydrogen bond with the ligands, the adduct with

Page 51: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

34

mutant Mb were stronger. The bigger size residue like NH2Tyr, if present near the active site,

also prohibits the release of ligands from the heme center and hence increases the stability.

CN– and N3

–, which are rich in electrons, also show the similar effect with lesser intensity as

compared to neutral ligands (Figure 2.10).

Page 52: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

35

Figure 2.10 Characterization of WT and H64NH2 Mb ligand complexes. Electronic absorption spectra of (A) CO (B) NO, (C) cyanoferric and (D) ferric N3

– complexes of WT Mb (red solid line) and H64NH2Tyr (blue dashed line) Mb. The spectra were taken at 4 °C and the

samples were examined in 100 mM phosphate buffer at pH 7.0.

Page 53: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

36

2.3.6 Proposed mechanical feature

The above spectroscopic and electrochemical characterizations demonstrate the role of

the redox-sensitive NH2Tyr in the introduction of peroxidase activity in Mb (Figure 2.11). When

H2O2 is present in the active site of the mutant Mb, the amine functional group of the NH2Tyr

can abstract a proton from the H2O2, thereby forming the Fe-O-OH moiety (Compound 0). This

in turn loses one molecule of H2O to form the active ferryl radical cation (Compound I). The

presence of the hydroxyl and the amine groups on the NH2Tyr is absolutely essential for this

step as it involves an acid-base catalysis mechanism. The distal “pull” effect via the hydrogen

bonding network facilitates heterolytic cleavage of the hydroperoxide-ferric O-O bond in

Compound 0. The substrate can now approach the ferryl (FeIV

) radical species become

oxidized, thereby regenerating the resting ferric state in the mutant Mb.

This indicates that the redox-properties of NH2Tyr can be exploited to generate the

elusive ferryl radical cation (Compound I) in the mutant Mb. Hence, H64NH2Tyr Mb

peroxygenase activities as well as isolation of catalytically active species in this mutant will

significantly increase our understanding of how nature utilizes the heme iron cofactor and the

protein scaffold around the active site in essential biological transformations involving peroxides

and O2.

Page 54: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

37

Figure 2.11 Mechanism of oxidation of NH2Tyr which releases 2 electrons and two protons to produce quinone product in the presence of an oxidant [O], such as H2O2.

2.4 Conclusions

In this chapter, I report the creation of a genetically engineered Mb mutant by

incorporating a non-canonical redox-active NH2Tyr into its active site. The replacement of His in

the distal His 64 with NH2Tyr mutant Mb provided an insight into the role of the distal binding

site residues in acid-base catalysis and distal charge relay “pull” effect in peroxide activation

and formation of ROS in heme proteins. The H64NH2Tyr mutant Mb showed high turnover rates

for thioanisole oxidation (9 times) and benzaldehyde oxidation (81 times) when compared with

the WT Mb, in the presence of H2O2. The ligand binding studies also explored the importance of

redox residues (e.g., NH2Tyr) near the heme center.

Page 55: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

38

CHAPTER 3

INTRODUCTION OF PEROXIDASE ACTIVITY IN MYOGLOBIN BY INCORPORATING

UNNATURAL AMINO ACIDS AT THE DISTAL HISTIDINE POSITION

3.1 Introduction

Among the various heme containing metalloproteins, Mb is found in the muscle tissue

of most vertebrates and all mammals (2). It is an oxygen binding single chain globular protein

with 153 amino acids (sperm whale Mb) (1, 2, 5). The binding site of Mb contains iron-heme as

the prosthetic group (105). Since Mb has been extensively characterized, it is frequently used

as a model to study the structure and function of the heme proteins. X-ray crystallography,

NMR, and EPR, have been successfully used to study the structure and function of the Mb

protein (106-108). The Mb gene of many organisms, including human and sperm whale, have

been cloned, and heterologous expression of recombinant protein in E. coli has been carried

out effectively (10, 109-112).

While studying other heme-proteins, like horseradish peroxidase (HRP) and

cytochrome c peroxidase (CcP), it has been revealed that the presence of distal His is very

critical for the formation of compound I and peroxidase activity (Figure 3.1) (106-108, 113-115).

The successful oxidation of thioanisole and benzaldehyde by HRP and CcP has demonstrated

their peroxidase property. In contrast, the rate of formation of compound I in Mb is quite slow

and the myoglobin compound I (Mb Cpd I) is also very unstable, hence the WT Mb cannot

catalyze sulfoxidation of thioanisole or benzaldehyde oxidation significantly. To carry out these

reactions, it is essential to increase the rate of compound I formation and provide a suitable

environment at the active site to prohibit its decay to compound II. The compound II is a

Page 56: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

39

catalytically inactive and stable iron-oxygen species, which effectively stores the oxygen in the

tissues.

A Binding site of WT Mb

B Active site of HRP

Figure 3.1 Schematic representation of the formation of compound I and compound II in Mb and HRP. (A) Formation of compound II by homolytic cleavage of O-O bond in Mb; (B) Compound I formation in HRP by heterolytic cleavage.

In order to increase the rate of formation of compound I and to stabilize it, we have

incorporated an unnatural amino acid, DOPA, replacing the distal His in the binding site of Mb.

This H64DOPA Mb mutant was constructed on the basis of accommodating a redox-sensitive

amino acid in the binding site of Mb. Oxidation of thioanisole and benzaldehyde were carried

Page 57: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

40

out in the presence of WT and mutant Mb to monitor their peroxidase property. Herein, we

report that the H64DOPA Mb mutant exhibited significantly high peroxidase activity as

compared to the WT Mb.

Furthermore, I have studied the electron rich and neutral ligand adducts of mutant and

WT Mb to understand the effect of redox amino acids such as DOPA, which is capable of giving

electrons to heme center and to ligand when present near the active site. It also was interesting

to explore the role played by hydrogen bonding favoring residues on the stability of ligand

adducts.

3.2 Experimental procedures

3.2.1 Chemicals

The gasses (O2, NO, CO and N2) were purchased from Air Liquide while DOPA,

Na2S2O4, sodium azide, potassium cyanide, thioanisole, benzaldehyde, and 30% H2O2 were

purchased from Sigma-Aldrich USA, and have been used without any further purification. All

chemicals were of analytical grade.

3.2.2 Preparation of WT Mb and H64DOPA Mb mutant constructs

The WT Mb and H64DOPA Mb expression constructs were made by the following

previous method (30). The H64DOPA Mb expression vector and tRNA synthetase plasmid have

been co-transformed in DH10B E.coli. The double antibiotic resistant colonies were picked,

grown, and the cell stocks were stored at –80 °C prior to protein purification.

3.2.3 WT Mb and H64DOPA Mb protein purification and analysis

The H64DOPA Mb was expressed in E. coli that was grown in GMML containing 25%

LB media and suitable antibiotics (ampicillin and tetracycline). Both the WT and mutated

Page 58: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

41

(H64DOPA) Mb proteins were expressed, purified and analyzed as described in chapter 2

(Figure 3.2).

Figure 3.2 Analysis of WT and H64DOPA mutant Mb by SDS-PAGE and MALDI-TOF. (A) Lane 1, expressed WT Mb; Lane 2, expressed H64DOPA Mb; Lane 3, Molecular weight standards as indicated in kDa (B) MALDI-TOF of the H64DOPA mutant Mb protein. A mass of 18397 Da matches the calculated mass for the Mb mutant. No WT protein (predicted mass, 18356 Da) was observed.

Page 59: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

42

3.2.4 Spectroscopy

UV-visible electronic absorption spectra of the WT Mb and mutant Mb proteins were

taken using Varian Cary 50 Bio UV-visible spectrophotometer. The concentration of WT and

mutant Mb was determined by heme chromatogen method (96).

3.2.5 Effect of H2O2

The effect of H2O2 on ferric proteins has been observed in the presence of 5 mM H2O2.

The protein concentration was 5 μM and heme bleaching of proteins was observed at 20 °C.

3.2.6 Preparation of oxyferrous complex

The oxyferrous complexes were prepared in a chest freezer at –45 to –55 °C. The

protein sample was taken in 100 mM potassium phosphate buffer (pH 7.0) which containing

65% glycerol (v/v). The ferric protein was first degassed with N2 gas for 2 hr Then, it was

reduced to deoxyferrous by addition of Na2S2O4 (20 mg/mL stock) under N2 atmosphere in a

sealed cuvette at 4 °C. Pre-cooled O2 gas was bubbled into the cuvette for 60 sec and the UV-

visible spectra were recorded.

3.2.7 Preparation of CO, NO, CN– and N3

– adduct samples

The ferrous-CO adducts were generated by gentle bubbling of CO in deoxyferrous

enzymes for 30 sec at 4 °C in 0.1 M potassium phosphate buffer pH 7.0. To prepare the

ferrous-NO adducts, minimal amount of buffer saturated with NO gas was added to the

deoxyferrous enzymes under N2 at 4 °C in 0.1 M potassium phosphate buffer pH 7.0. The ferric

N3– and cyanoferric adducts were formed by addition of minimal amounts of NaN3 and KCN

from their respective stocks (40 mM NaN3 and 1 M KCN) to the degassed ferric proteins. The

ferric proteins were in 100 mM potassium phosphate buffer pH 7.0 and the temperature was 4

Page 60: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

43

°C. The deoxyferric enzymes were prepared by bubbling of N2 gas in the ferric enzymes for at

least 30 min.

3.2.8 Catalytic sulfoxidation of thioanisole and oxidation of benzaldehyde

The reactions were performed and the products were analyzed as described in chapter

2 and the data were shown in figure 3.8 and table 3.2.

3.2.9 Electrochemical instrumentation

DPV was carried out following the method as described in chapter 2 and the data were

shown in figure 3.7.

3.3 Results and discussion

The inherent property of Mb is to store and transport oxygen. The WT Mb forms a

stable and catalytically inert oxy-complex. It has been reported that the His 64 stabilizes the

sixth ligand water molecule through hydrogen bonding (110, 116, 117).

3.3.1 UV-visible spectroscopic characterization of WT and H64DOPA mutant Mb

The mutant protein and WT Mb exhibited similar electronic spectra as observed for the

ferric heme species. The maximum absorbance in Soret band was found to be 409 and 411 nm

for the WT and mutant Mb, respectively (Figure 3.3). In the case of WT Mb, small peaks were

observed at 632 nm, 580 nm, 544 nm, and 507 nm, while for H64DOPA Mb, only two peaks

were observed at 632 nm and 530 nm in addition to the 411 nm peak. His 64 has been replaced

by DOPA and the unnatural amino acid was expected to stabilize it further by forming an extra

hydrogen bond. Therefore, I have genetically encoded DOPA into Mb, replacing His 64 with the

amber nonsense codon TAG into a pBAD expression vector, using a previously reported

technique. The method includes the genetic incorporation of non-canonical amino acids into

Page 61: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

44

proteins using orthogonal tRNACUA/aminoacyl-tRNA synthetase pairs in bacteria. Mass spectral

analysis (MALDI-TOF) showed a parent ion mass of 18597 Da as expected for the H64DOPA

Mb mutant (Figure 3.2 and Figure 3.3).

Furthermore, the H64DOPA Mb mutant showed remarkable tolerance to H2O2. Even at

25 mM concentration of H2O2, heme bleaching was not observed to a significant extent (Figure

3.4). The UV-visible absorption spectrum of H64DOPA Mb mutant in presence of H2O2 also

exhibited a Soret band at 411 nm similar to that of ferric resting species. However, the

isosbestic points present in the spectra indicate that an active catalytic species had been

formed (Figure 3.3). Under similar conditions, when H2O2 was added to the WT Mb, hemin was

bleached out and it formed an inactive compound II species as expected. This fact was verified

by the presence of a Soret at 418 nm (Figure 3.4) in the absorption spectrum of the WT Mb.

Figure 3.3 High-valent heme complexes of WT and H64DOPA Mb. Electronic absorption spectra of the H64DOPA Mb in presence (black solid line), in absence (red dashed line) and WT Mb in presence (green dotted line) and in absence (blue dashed dot line) of 5 mM H2O2.

Page 62: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

45

Figure 3.4 Stability of WT and H64DOPA Mb in presence of H2O2. Absorbance changes monitored over a 30 min period at λmax = 418 nm for WT Mb (blue dashed), λmax = 410 nm for H64DOPA mutant Mb (black dash dot line) in the presence of 5 mM H2O2.and control protein without H2O2 (red solid line) The spectra were measured in 100 mM potassium phosphate buffer, pH 7.0 at 20 °C with 10 μM protein.

Page 63: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

46

3.3.2 Deoxyferrous and oxyferrous species of WT Mb and H64DOPA Mb

The substrate free ferric (low spin) of WT Mb and H64DOPA Mb have been reduced to

ferrous (high spin) with the Na2S2O4 in 65% (v/v) glycerol under N2 at 4 °C. The deoxyferrous

protein shows a shift in the Soret from 409 to 430 nm and from 411 to 432 nm in WT Mb and

mutant Mb respectively (Figure 3.5). In the visible region, a peak at 558 nm was observed in the

deoxyferrous WT Mb, while in mutant H64DOPA Mb, peaks were observed at 560 nm and 515

nm (118).

Figure 3.5 Deoxyferrous and oxyferrous spectra of WT and H64DOPA mutant Mb. The absorption spectra of WT Mb deoxyferrous (blue dashed dot line), H64DOPA Mb deoxyferrous (red dashed line), WT Mb oxyferrous (green dotted line) and H64DOPA Mb oxyferrous (black solid line) species. The spectra were taken at –35 to –45 °C and the samples were examined in 65% glycerol, 100 mM phosphate buffer at pH 7.0.

In the oxyferous WT Mb and mutant H64DOPA Mb, Soret bands at 416 nm and 418 nm

were observed, respectively. In the visible region, peaks at 581 nm and 540 nm for the WT Mb

and at 580 nm and 536 nm for the mutant H64DOPA have been recorded. Since DOPA can

Page 64: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

47

give electrons to the heme and can also participate in hydrogen bonding, the Soret (λmax = 418)

has been observed to be sharper in the mutant protein as compared to WT mb. (Figure 3.5)

3.3.3 CO, NO, CN– and N3

– adducts of WT and H64DOPA Mb

Figure 3.6 clearly indicates that when CO is bound to the enzyme, the Soret (λmax =

422) became sharper for the ferrous enzyme bonded with CO. As Fe-CO is a linear adduct and

both the π orbitals are empty, it allows dπ-π orbitals to overlap in a perpendicular direction,

making the sharper Soret (104). Under similar conditions addition of NO and O2, (because of

having one or two electrons in their orbitals) reduce the chances of backbonding. These

adducts were stronger in the case of mutant protein because of the formation of extra hydrogen

bonding. The electron rich ligands such as CN– and N3

– have similar effects with less intensity

as π backbonding was observed less in these cases (32, 119).

Page 65: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

48

Page 66: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

49

Figure 3.6 Study of WT and H64DOPA Mb ligand complexes. The electronic absorption spectra of (A) CO (B) NO, (C) cyanoferric and (D) N3

– complexes of WT Mb and H64DOPA Mb. The spectra were taken at 4 °C and the samples were examined in 100mM phosphate

buffer at pH 7.0.

Page 67: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

50

3.3.4. Redox potentials of WT and mutant Mb

Both the WT and the mutant H64DOPA Mb were further analyzed to obtain their redox

potential. The electrochemistry of the protein solutions were probed by differential pulse

voltammetry. The redox potential of WT and mutant H64DOPA Mb protein in the absence of

H2O2 WT were found to be the same, i.e., –232 mV, while in the presence of H2O2 it was

observed to be –260 mV and –300 mV, respectively (Figure 3.7 and Table 3.1). This

observation was expected as H2O2 was bonded to the heme center (120). The binding of H2O2

to the heme center replaced the H2O molecule, which was the sixth ligand, and a high spin

ferric state was formed. The difference in the reduction potential also removed the energy

barrier of electron transfer to the heme center (79, 120). Upon addition of H2O2 in the mutant

H64DOPA Mb protein, the reduction potential had decreased, which clearly indicates that an

extra hydrogen bond is formed at the active site of the mutant protein when compared to the

WT Mb binding site (121).

Table 3.1 Reduction potential of WT Mb and H64DOPA Mb mutant at pH 7.0 and pH 10.0 in presence and absence of H2O2 as obtained from DPV. All protein concentrations were 5 µM and the potentials were recorded vs. Ag/AgCl (3.5 M KCl).

Reduction Potential, E (V)

Protein

Without H2O2

With 5mM H2O2

pH 7

pH 10

pH 7

pH 10

WT Mb

–0.232

–0.256

–0.260

–0.292

H64DOPA Mb

–0.232

–0.244

–0.300

–0.268

Page 68: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

51

Figure 3.7 Reduction potential of WT and H64DOPA Mb in presence and absence of H2O2 at pH 7.0 and at pH 10.0. The DPV response of 5 µM WT and mutant H64DOPA Mb in nitrogen saturated 100 mM phosphate buffer and 10 mM KCl solutions (A and C: at pH 7.0; B

Page 69: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

52

and D: at pH 10.0) in presence (A and B) and absence (C and D) of H2O2 at room temperature conditions. Pulse amplitude = 30 mV, step size = 4 mV, pulse duration = 0.05 sec and pulse period = 0.20 sec.

Page 70: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

53

3.3.5 Thioanisole sulfoxidation and benzaldehyde oxidation

As reported earlier (98, 122), WT Mb reacts with H2O2 and forms ferryl heme (FeIV

=O)

equivalent to compound II. Compound I has never been isolated, as it is highly unstable, which

makes peroxidase activity of the WT Mb very low. It was observed that, in the presence of H2O2,

WT Mb converts only 14% (Figure 3.8) thioanisole to sulfoxide with the turnover rate of 0.25

min–1

which matches with the literature reports (Table 3.2). But under identical conditions,

H64DOPA Mb converts 97% (Figure 3.8) thioanisole to its sulfoxide with a turnover rate of 2.5

min–1

. Thus the turnover rate of sulfoxidation is 10 times higher in the case of the mutant

H64DOPA Mb than that of WT Mb.

Page 71: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

54

Figure 3.8 GC analysis of thioanisol and benzaldehyde oxidation. Conversion of thioanisole (a) to its sulfoxidation product (b), (A) WT Mb, (B) H64DOPA Mb. (C) and (D) show oxidation of benzaldehyde (a) to benzoic acid (b) by WT Mb and H64DOPA Mb respectively. The reaction mixture contained 5 µM Mb and 5Mm H2O2.

Page 72: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

55

Furthermore, H64DOPA Mb converts 80% (Figure 3.8) benzaldehyde to benzoic acid

with 2.5 min–1

turnover rate (Table 3.2) while under similar conditions WT Mb converts 2%

(Figure 3.8) benzaldehyde to benzoic acid with 0.01 min–1

turnover rate (Table 3.2). The

turnover rate of benzaldehyde to benzoic acid was 54 times higher by mutant H64DOPA Mb as

compared to the WT Mb.

Table 3.2 Rate of sulfoxidation of thioanisole reaction (Rxn 1) and benzaldehyde oxidation reaction (Rxn 2) by WT and H64DOPA mutant Mb.

Protein

Rates (min–1

)

Rxn 1

Rxn 2

WT Mb

0.25

0.05

H64DOPA Mb

2.5

2.67

In addition to the above experiments, ABTS oxidation reaction assays of Mb and its

H64DOPA mutant Mb in the presence of 5 mM H2O2 were also carried out at pH 7.0 and at 4

°C. The kinetic values and turnover factor for the WT and the mutant H64DOPA Mb were

calculated based on the data obtained. The H64DOPA mutant Mb exhibited a Km of 0.67 ×103

µM, while that for the WT Mb was 19.3 µM, which corresponded to the literature value. The Vmax

for the WT and the mutant was observed to be 25.6 and 15.2 µM min–1

, respectively (Table 3.3)

(100).

Page 73: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

56

Table 3.3 Peroxidase assay of WT and H64DOPA mutant Mb with ABTS in presence of H2O2. ABTS oxidation reaction with WT Mb and its H64DOPA mutant Mb in the presence of 5 mM H2O2. Kinetic values are based on the average of at least 2 determinations and the unit for rate is turnover per min. Reaction has been done at pH 7.0 and at 4 °C.

[a] This value is in agreement with data previously reported

Significantly enough, under similar conditions, epoxidation of styrene did not form

substantial amounts of the epoxide product (result not shown). In order to explain the observed

catalytic reactions and the non-formation of epoxides, we propose that the formation of

compound I was achieved through general acid base catalysis. The hydroxyl groups of the

DOPA facilitate the mechanism (Figure 3.9) as they are closer to the heme center and can form

a hydrogen bond with H2O2. The extra hydrogen bond is instrumental in stabilizing the

compound I species in the mutant H64DOPA Mb, which further generates the peroxidase

activity in the mutant Mb.

Protein

Km (µM)

Vmax (µM min–1

)

WT Mb

19.3 [a]

25.6 [a]

H64DOPA Mb 0.67 × 103 15.2

Page 74: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

57

Figure 3.9 Proposed acid-base catalytic mechanism for compound I formation in H64DOPA mutant Mb in presence of H2O2.

3.4 Conclusion

In this chapter we report the incorporation of an unnatural amino acid to a specific place

in the binding site of Mb. The mutant H64DOPA Mb is an active and stable protein. It could

carry out the oxidation of two substrates, namely, thioanisole and benzaldehyde with 20 to 40

fold higher catalytic rate in mutant Mb as compared to WT Mb. In addition, our observations

support the idea that the distal His is important for the formation of compound I. In order to

exhibit peroxygenase activity in Mb, the mutation of the distal His with an unnatural amino acid

assisted in substrate binding at the active site and enhanced the compound I formation. In

addition, the ligand binding studies demonstrate electron deficient ligands exhibit sharper Soret

than the electron rich ones for the mutant protein.

Page 75: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

58

Page 76: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

59

CHAPTER 4

FAVOURABLE BINDING SITE ORIENTATION IN MYOGLOBIN FOR DIRECT ELECTRON

TRANSFER, ELECTROCATALYSIS AND MICROARRAY INVESTIGATION

4.1. Introduction

Much attention has been focused in recent years on the immobilization of

proteins on electrode surfaces (123-126). Such studies are driven by possible applications in a

broad range of chemical, biological, and medical technologies spanning bioelectrocatalysis,

biomaterials, and biosensors (127-129). Further, immobilized protein assemblies provide a

versatile platform for designing mechanistic studies on heterogeneous electron transfer

between a cofactor and an active center of a protein. However, direct electron transfer (DET)

between proteins and the electrode surface, which can provide new mechanistic insights, is

difficult to achieve, mainly due to the lack of good immobilization techniques. Most of the current

immobilization techniques show denaturation of the protein on adsorption on the electrode

surface. Unfavorable active site orientation of the protein during random adsorption process on

the electrode also hinders DET. Strategies to circumvent these difficulties include the use of

organic mediators (e.g., dye molecules, conducting polymers, etc) and protein films which again

can lead to denaturing of the proteins (130-133). In the past, various immobilization methods

have been employed to immobilize proteins on the electrode surface. For example, non-

covalent attachment of proteins (134, 135), entrapment in porous matrix (136-138),

nanoparticles (139, 140), and sol gels (141-143) have been extensively studied. There are also

some reports of covalent immobilization of proteins on the surface of the electrodes, where

either chemically modified protein (which often leads to protein denaturation due to harsh

chemical treatment) or the functional groups (such as Cys, Arg, Lys, Asp, Glu, etc.) available on

Page 77: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

60

the surface of the proteins have been utilized to covalently attach the protein onto the suitably

modified electrode surface (123, 144-146).

Mb is a water soluble heme containing protein, which is present in all mammals and

vertebrates, and has been used extensively for investigating electron transfer and

electrocatalysis with the protein immobilized on an electrode surface. Its main function is to

store oxygen and enhance diffusion of oxygen in the muscle. This globular protein has a single

153 or 154 amino acid chain as in sperm whale, with a molecular weight of ~17 kDa (147). It is

a versatile protein with high tolerance for chemical and mechanical environments and can be

easily expressed and purified in large quantities in E. coli. Another important feature is that it

can accommodate various mutations without any adverse effects on its conformational and

functional properties (19, 24, 148). Mb contains a single iron-porphyrin center (heme b) that can

accommodate ferrous, ferric or ferryl oxidation states within this heme active site moiety. For

these reasons Mb has become an accepted natural model for exploring redox functional

properties and electron transfer reactions in electrochemistry (149-152). For example, co-

adsorption of Mb with surfactants like sodium dodecyl sulfate or cetyltrimethylammonium

bromide on various electrodes such as glassy carbon, pyrolytic graphite, and platinum was

reported (150). These protein films were utilized for the electrocatalytic reduction of 1,2-

dibromocyclohexane and trichloroacetic acid (150). In the case of immobilization of Mb, a self-

assembled monolayer using L-cysteine (L-Cys) on the modified electrode surface exhibited DET

between the protein active site and the electrode as well as good electrocatalytic activity toward

ascorbic acid oxidation (151).

Even though a wide range of reports are available for immobilization of proteins for

carrying out DET and electrocatalysis with electrodes, a direct comparison involving active site

orientation of monolayer and multilayer covalent attachment of proteins is absent. This is mainly

due to the difficulty to achieve a site-directed covalent tagging of the native conformation of Mb

on the surface with the full control over active site orientation. Furthermore, formation of both a

Page 78: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

61

monolayer as well as a multilayer on the electrode surface is a challenging task. Herein we use

a unique biochemical technique based on the incorporation of an unnatural amino acid in vivo to

generate a native Mb protein with additional functional groups (92, 153). NH2Tyr was genetically

encoded with the amber nonsense codon, TAG, by means of a previously evolved orthogonal

tRNACUA/aminoacyl-tRNA synthetase pair that is specific for NH2Tyr (154). The S3NH2Tyr

mutant Mb was immobilized by forming a benzoxazine ring through a Diels-Alder reaction in

buffer (155). This provides an effective strategy for covalent immobilization of a single

monolayer of Mb mutant on a gold electrode surface without impairing its electroactivity (Figure

4.1A). The random multiple covalent attachment of the WT Mb was achieved through 1-ethyl-3-

(dimethylamino-propyl) carbodiimide (EDC)-catalyzed bioconjugation reaction. The DET

characteristics and electrocatalytic behavior of such random multilayered assembly of

covalently-bound WT Mb counterpart (Figure 4.1B) are compared in this study with a site-

directed monolayer protein on the gold surface.

Due to its ability to perform total genomic analysis, DNA microarray has revolutionized

the genomic biotechnology. Likewise, protein microarray has the potential to generate advanced

bioinformatics platforms for proteomics and it could transform the field of drug discovery,

medical diagnostics, and biochemical analysis. Development of functional protein microarray is

more difficult than DNA, peptide, and antibody microarrays. Strong attachment of proteins on

surface, native protein conformation, homogeneous protein monolayer, control over active site

orientation, and retention of protein activity have been the major problem while dealing with

protein microarray.

In order to understand the role of the amino acid residues which are located far from the

active site such Ser 3 in ligand adduct formation, we have extensively formed and studied

ligand adducts with various ligands such as CO, NO, O2, CN–, and N3

– in this chapter.

Page 79: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

62

Figure 4.1 Graphical representation of WT and S3NH2Tyr mutant Mb attachment on modified gold electrodes. (A) Ser 3 replaced with NH2Tyr Mb, with its heme active site; which leads to site-directed covalent attachment, with full control over active site orientation, of S3NH2Tyr Mb mutant on the modified gold electrode; (B) WT Mb (PDB: 1MBO) with all surface-exposed amino acids are shown, aspartate and glutamate in red color (with acidic side-chains) and arginine and lysine in blue color (with basic side-chains) as points of immobilization for the bioconjugated crosslinking of the WT Mb proteins. Orange ellipses represent random active site orientation (with limited substrate accessibility) of bioconjugated protein cluster.

Page 80: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

63

4.2 Experimental procedures

4.2.1 Chemicals

L-Cys, tetraethyleneglycol diacrylate (TEGDA), sodium periodate (NaIO4) and

N,N-di-iso-propylethyl amine (DIPEA) were obtained from Sigma-Aldrich USA and were used

without further purification. All chemicals were of analytical grade.

4.2.2 Preparation of WT Mb and S3NH2Tyr mutant Mb constructs

The WT Mb expression construct (pBAD with ampicillin resistant marker), S3NH2Tyr Mb

gene expression vector (pBAD with kanamycin resistant marker) and aminoacyl tRNA

synthetase (aatRNA S) with tetracycline resistant marker vector (PAC) were a gift from Dr.

Peter Schultz (The Scripps Research Institute, La Jolla, CA USA). The S3NH2Tyr Mb

expression vector and tRNA synthetase plasmid were co-transformed in DH10B E. coli cells.

The double antibiotic resistant colonies were picked, grown, and the cell stocks were stored at –

80 °C prior to protein expression.

4.2.3 WT Mb and S3NH2Tyr Mb protein purification and analysis

The S3NH2Tyr Mb was expressed in DH10B and was grown in GMML containing

ampicillin and tetracycline antibiotics and the unnatural amino acid, NH2Tyr. The WT and

S3NH2Tyr Mb mutated proteins were expressed, purified, and analyzed as described in chapter

2 (Figure 4.2). The mass of mutant S3NH2Tyr Mb protein mass was analyzed by MALDI-TOF

and was observed to be 18446 Da (Figure 4.3), which matched with the theoretically calculated

mass.

Page 81: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

64

1 2 3

Figure 4.2 Coomassie-stained sodium SDS-PAGE analysis of S3NH2Tyr Mb and WT Mb proteins. Lane 1, expressed WT Mb; Lane 2, expressed S3NH2Tyr Mb mutant in presence of 1 mM NH2Tyr; Lane 3, molecular weight standards as indicated in kDa unit.

15 kDa

20 kDa

150 kDa

Page 82: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

65

Page 83: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

66

Figure 4.3 Electrospray ionization-time of flight-mass spectrometry (ESI-TOF-MS) analysis of the incorporation of S3NH2Tyr into S3 (TAG) Mb mutant showing a mass of 18446 Da (calculated mass, 18446 Da) for S3NH2Tyr Mb.

Page 84: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

67

4.2.4 UV-vis spectroscopy

UV-visible spectra were acquired on a Cary 50 Bio UV-visible spectrophotometer. The

concentrations of the WT and mutant Mb were determined from the absorption spectrum of the

protein, using an extinction coefficient of 170 mM–1

cm–1

at 410 nm.

4.2.5 AFM measurements

The experiments were performed with a Veeco MultiMode V SPM instrument. The

cantilevers used in this experiment were made of P-doped n-type Si. The cantilever was

oscillated in the constant excitation mode. Tapping mode Atomic force microscopy (AFM)

images were acquired in the constant frequency shift mode using frequency modulation (FM)

detection. Data analysis was done with the diNanoscope software 7.0.

Page 85: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

68

4.2.6 Ligands adduct formation

The protein samples containing 65% glycerol (v/v) were taken in airtight cuvettes

containing 0.1 M potassium phosphate buffer pH 7.0 and were degassed with the N2 gas for ~2

hr at 4 °C and then reduced with minimal amount of Na2S2O4 (in µL) from the stock of 20

mg/mL. In a chest freezer at –35 to –45 °C containing the above sample, pre-cooled O2 gas

was bubbled for 60 s and the UV-visible spectra were recorded. The ferrous-CO adducts were

generated by gentle bubbling of CO in the deoxyferrous enzymes under N2 for 30 s at 4 °C in

0.1 M potassium phosphate buffer pH 7.0 while ferrous-NO adducts were generated by µL

addition of buffer saturated with NO gas. Ferric azide and cyanoferric adducts were prepared by

addition of minimal amount of NaN3 and potassium cyanide solution from their respective stocks

4.2.7 Preparation of microarray

Clean glass slides were silanized, extended, and acryloyl functionalized. To obtain a

pegylated linker, extended acryloyl glass slides were obtained from amine-coated glass slide by

treating with 1 mM diisopropylethylamine followed by reaction with 1 mM tetra (ethylene glycol)

diacrylate in dry dimethylformamide (DMF). In the presence of 100 µM NaIO4, at room

temperature, the mutant protein (3NH2Tyr incorporated) was attached to the pegylated acryloyl

glass slide, for 2 hr The slides were washed in 100 mM potassium phosphate and water for 2

hr. At room temperature, carbonic anhydrase (CA) catalytic assay was carried out using p-

nitrophenyl acetate (0.1 mM) in 15 mM Tris buffer (pH 7.6). Using Veeco Multimode V SPM

instrument, AFM measurements were recorded for glass chip-bound proteins. To prepare

microarrays, proteins were mixed with 0.1 mM NaIO4 for 10 min prior to printing in a solution of

100 mM potassium phosphate buffer (pH 6.0). BioRobotics MicroGrid II 600 with an internal

chamber humidity of 70% was used for printing. After printing, before being transferred to

phosphate buffered saline (PBS) buffer (pH 7.5) for 48 hr of washing, proteins were allowed to

bind for 4 hr at room temperature. With a 1:500 dilution in PBS buffer containing 1% bovine

Page 86: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

69

serum albumin (BSA) and 0.1% Tween 20 for 1 hr, binding of HiLyte 647 fluorophoretagged

anti-6xHis tag rabbit Immunoglobulin G (IgG) was performed, followed by washing in PBS buffer

containing 0.1% Tween 20 for 5 min twice. Using Coomassie bromophenol blue staining

solution, Coomassie staining was done for 10 min, followed by 24 hr of washing in water.

4.2.8 Electrochemical instrumentation and procedures

Cyclic voltammetry (CV) was carried out using a three-electrode cell at 22 °C on a

CHI720C electrochemical analyzer (CH Instruments, Austin, TX). The working electrode was

polycrystalline gold (1 × 1 cm2 in area, Alfa Aesar), the counter electrode was a platinum wire,

and the reference electrode was Ag/AgCl (3.5 M KCl). The counter electrode and reference

electrode were obtained from CH Instruments. All potential values below are reported with

respect to the Ag/AgCl (3.5 M KCl) reference electrode. The working electrode surface was first

polished on microcloth (Buehler No. 40-7212) with alumina slurry suspension (0.05 μm), then

sonicated in ethanol, and finally rinsed thoroughly with Milli-Q water. The electrolyte solution

was 0.1 M potassium phosphate buffer with 10 mM KCl solutions at pH 7.0. The solutions were

deoxygenated by bubbling nitrogen prior to each experiment. The CV measurements were

recorded at potential scan rates ranging from 0.05 Vsec–1

to 0.5 Vsec–1

.

4.2.9 Electrode modification procédures

4.2.9.1 Au/L-Cys/WT Mb

The freshly polished and clean gold electrode was immersed in a 2 mM ethanol

solution of L-Cys for 2 hr. It was then washed thoroughly and immersed in the 5 µM WT Mb

solution in MES buffer at pH 5.0. To this solution, a freshly prepared aqueous solution of EDC

was added and the electrode was incubated in this protein medium (2 mL) overnight at 4 °C.

The electrode was then removed, rinsed thoroughly with Milli-Q water, and allowed to dry under

nitrogen flow before use.

Page 87: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

70

4.2.9.2 Au/L-Cys/TEGDA/ S3NH2Tyr Mb

The freshly polished and clean gold electrode was immediately immersed in a 2 mM

ethanolic solution of L-Cys for 2 hr. It was then washed thoroughly and immersed in 20 mM

N,N-di-iso-propyl-ethylamine in dimethylformamide (2 mL). To this solution, 10 mM

tetraethylene glycol diacrylate was added and the electrode was kept in it for 3 hr. The

S3NH2Tyr Mb was added in phosphate buffer solution and an aqueous solution of 100 µM

NaIO4 was added to it. The chemically-modified gold electrode was washed thoroughly to

remove any traces of unreacted molecules and incubated in the mutant protein solution

overnight at 4 °C. The electrode was then removed, rinsed with Milli-Q water thoroughly for 1 hr,

and allowed to dry under nitrogen flow before use.

4.2.9.3 Electrocatalysis

Electrocatalysis was carried out in 8 mL of potassium phosphate buffer (100 mM at pH

7.0) containing 5 mM thioanisole dissolved in 30% t-butanol. O2 was bubbled into the solution

throughout the reaction time. Bulk electrolysis was then performed for 2 hr at a constant

potential of –0.50 V. On completion of the catalytic cycle, the organic products were extracted in

dichloromethane (3 × 2 mL). The solution was concentrated, and the products were analyzed by

GC.

4.3. Results and discussion

4.3.1 Monolayer vs. multilayer covalent immobilization of Mb on Au

A central challenge in designing an Mb array for DET is that the electro-active heme

centers are randomly oriented within the protein matrix. Further, conversion of heme protein into

a protein film on the electrode surface may also lead to heme bleaching and protein denaturing

(156-158). To address these challenges, a mild and native immobilization strategy was

Page 88: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

71

developed. In this study, site-directed mutagenesis was used to incorporate an unnatural amino

acid (Scheme 4.1) to immobilize Mb on the gold electrode as a monolayer using a unique Diels-

Alder reaction in water or buffer at room temperature or 4 °C (155). The Ser 3 group replaced

with an NH2Tyr of the Mb provides an ideal basis for this reaction as it is solvent exposed at that

position as well as it orients the active site away from the surface.

Page 89: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

72

Scheme 4.1 Schematic representation of Au electrode modification for monolayered- immobilization of S3NH2Tyr Mb mutant on the Au surface; see text for details.

Page 90: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

73

Incorporation of NH2Tyr into the protein was carried out by using orthogonal

tRNACUA/aminoacyl-tRNA synthetase pairs in bacteria. The mutant Mb was analyzed by SDS-

PAGE (Figure 4.2) and MALDI-TOF (Figure 4.3). Surface modification of the gold electrode was

initiated by modifying it first with an amine-functionalized thiol surface (Scheme 4.1). This

chemically-modified surface was reacted with tetraethyleneglycol diacrylate to obtain the

acroylyl moiety on the surface. Note that the tetraethyleneglycol portion serves to also provide a

lipid-like environment to the covalently attached protein, thus protecting its native conformation

on the surface. In the presence of mild oxidant NaIO4, the NH2Tyr on the surface of the

S3NH2Tyr Mb mutant was easily oxidized to form the o-iminoquinone. This intermediate, in turn,

underwent a Diels-Alder cyclo-addition reaction with suitable alkenes to form a benzoxazine

moiety. The entire process of the covalent attachment of mutant S3NH2Tyr Mb onto the acryloyl

derivatized gold electrode surface was carried out under ambient or 4 °C temperature. The

mutation at Ser 3 with the unnatural amino acid, NH2Tyr, enables full control of the orientation of

the active site of the protein, when covalently immobilized onto the modified gold electrode

(Figure 4.1A). Thus the catalytic and electro-activity of the heme can be easily achieved even

when the mutant protein is covalently attached to the surface of the electrode.

To immobilize the WT Mb as a multilayer, a different strategy had to be employed

(Figure 4.1B). The presence of carboxylic acid and amine groups on the protein surface can be

utilized to form covalent cross linking bonds between these groups and also with suitably

modified, i.e., amine-functionalized, gold surfaces. This bioconjugation reaction is facilitated by

the amino acids with carboxylate groups, such as aspartate (20, 27, 44, 122, 126, and 141

positions), glutamate (4, 6, 18, 38, 41, 52, 54, 59, 83, 136, and 148), and amine groups, such as

arginine (31, 45, 118, and 139) and lysine (16, 34, 42, 47, 50, 56, 62, 63, 77, 78, 79, 96, 98,

102, 133, 140, 145, and 147 positions). Compounds such as 1-ethyl-3-(3-dimethylaminopropyl)

carbodiimide possessing the carbodiimide functional group can be successfully used for

crosslinking these amino acids to form amide linkages (159, 160). The EDC reaction chemistry

Page 91: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

74

(Scheme 4.2) was exploited in this study to covalently bind the WT Mb to the amine-

functionalized gold surface, as well as to bioconjugate the Mb as a polymer to generate Mb

multilayer with disoriented binding sites. The random orientation of the binding sites hinders

exposure of some of them to the solvent phase for catalytic or electrochemical activity.

Scheme 4.2 Schematic representation of multilayered WT Mb immobilization on the modified gold electrode surface using EDC catalyzed bioconjugation reaction. Inset: Graphical representation of WT Mb (PDB: 1MBO) with all surface-exposed amino acids. The aspartate and glutamate are represented in red color and arginine and lysine residues in blue color.

Page 92: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

75

The surface topography of the covalently attached Mb assemblies were probed

by AFM. Figure 2 compares the AFM images for a chemically-modified amine-functionalized Au

surface before (Figure 4.2a) and after S3NH2Tyr Mb mutant (Figure 4.2b) or WT Mb (Figure

4.2c) covalent attachment. While the pristine surface before protein attachment was featureless

(Figure 4.2 a), an average feature height of ~5 nm was observed in the case of the mutant

protein monolayer, which correlated to the actual size of the protein based on the X-ray

crystallographic structure of Mb (Figure 4.2b). On the other hand, covalently-attached WT Mb

was noticeably rougher, with an average feature height of ~175 nm (Figure 4.2c). As a control

experiment, the WT Mb was also immobilized on the acryolyl-derivatized gold electrode surface

using NaIO4 under the same reaction conditions as the S3NH2Tyr Mb mutant. However, as

expected by the absence of the o-iminoquinone moiety, the WT Mb did not form a monolayer on

the modified surface (Figure 4.3) compared to the genetically modified S3NH2Tyr Mb mutant

(Figure 4.2b). Since the covalent linkage is formed only between the o-iminoquinone moiety of

the protein and the acryloyl group on the modified electrode surface by the Diels-Alder reaction,

the WT Mb does not get covalently immobilized on the electrode surface.

Page 93: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

76

Figure 4.4 Tapping mode AFM topographic images for (a) chemically modified Au surface, (b) with immobilized S3NH2Tyr Mb mutant and (c) and with WT Mb on the surface.

Page 94: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

77

4.3.2 Electrochemical characterization

Cyclic voltammetry (CV) was used to study the DET electrochemistry of immobilized Mb

on the Au electrodes. In this study, though L-Cys and cysteamine were used to modify the gold

electrode surface (Figure 4.1 and Table 4.1), cysteamine-bound Mb failed to display reversible

redox properties in CV measurements (data not shown). Both WT Mb and the S3NH2Tyr Mb

mutant were immobilized on L-Cys functionalized surface to obtain the CV data. The results

show well defined redox electrochemistry when examined by CV from scan rates 0.05 Vsec–1

to

0.5 Vsec–1

(Figure 4.4). Immobilized Mb on modified Au electrode (CV)

Potential /V vs. Ag/AgCl

-0.4-0.20.00.20.4

Cu

rren

t /A

-6e-5

-4e-5

-2e-5

0

2e-5

4e-5

Au-LCys

Au-LCys-WT Mb

Au-LCys-TEGDA-S3NH2Tyr Mb

Figure 4.5 CV response of L-Cys-modified, WT Mb and S3NH2Tyr Mb mutant immobilized gold electrode in nitrogen-purged 100 mM phosphate buffer with 10 mM KCl (pH 7.0) at room temperature at potential scan rate = 0.1 Vsec

–1.

Page 95: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

78

Page 96: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

79

Figure 4.6 CV and peak current response of WT and mutant Mb. Mutant (A) S3NH2Tyr Mb and (C) WT Mb immobilized gold electrode in nitrogen-purged 100 mM phosphate buffer with 10 mM KCl (pH 7.0) at room temperature. Potential scan rate ranges from 0.05 to 0.5 V/sec. Plot of peak current vs scan rate for mutant S3NH2Tyr Mb (B) and WT Mb (D) immobilized on L-Cys modified gold electrode in nitrogen-purged 100 mM phosphate buffer with 10 mM KCl (pH 7.0) at room temperature. Potential scan rate ranges from 0.05 to 0.50 Vsec

–1

Page 97: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

80

It was observed that the peak currents were directly proportional to the scan rates,

which signals that the proteins were immobilized to the electrode surface (Figure 4.4). The peak

current, Ip for a surface confined reactant is given by Eq. 1 (161).

ART

FnI p

4

22

(Eq. 1)

where, n = number of electrons transferred, F = Faraday constant, R = universal gas

constant, T = absolute temperature in Kelvin (T = 295 K), A = surface area of the electrode, Γ =

surface coverage or the concentration of the redox-sensitive covalently immobilized Mb protein

in mol/cm2, υ = scan rate. From equation 1, the slopes of the plots were given by (n

2F

2/4RT) AΓ

and substituting the known values, such as the geometric area of the electrode surface (A = 2.0

cm2) and the other constants, the estimated values of the number of molecules of the enzyme

associated with the electrode surface (Γ) were 1.54 × 10–10

mol cm–2

for the S3NH2Tyr Mb

mutant protein immobilized on the modified gold electrode. Similarly, for the WT Mb protein, Γ

was 1.29 × 10–10

mol cm–2

on the modified gold electrode through the bioconjugation reaction. A

comparison of the surface coverage of the monolayered S3NH2Tyr Mb mutant and the

multilayered WT Mb indicated that random orientation of the binding sites in the multilayered

WT

Mb leads to lesser number of redox-sensitive proteins on the surface. In contrast, the

S3NH2Tyr Mb mutant allows proper orientation of the active site, thereby exhibiting

homogenously distributed redox-sensitive proteins on the electrode surface.

To investigate the influence of pH on the electron transfer between the active site of the

immobilized protein and the gold electrode, CV was carried out in solutions of different pH

ranging from 5 to 9. It was observed that with increasing pH, the reduction potential of the Fe-

center exhibited a linear negative shift (Figure 4.5). These data support the notion that

denaturation of the Mb protein did not occur within the pH range of 5 to 9.

Page 98: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

81

Table 4.1 Comparison of heterogeneous electron transfer rates of Mb on gold electrodes.

Surface modification used Approximate

theoretical length of

anchoring tether (Å);

molecule used

Heterogeneous

electron transfer

rate, ks (s–1

)

Reference

5.35

Homocysteine

0.93 (162)

4.75

L-Cys 1.66 (151)

4.75

L-Cys 2.26 This work

26.66

L-Cys-linked with

tetraethylglycol

diacrylate

1.25 This work

Page 99: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

82

Influence of pH on immobilized WT Mb and S3NH2Tyr Mb

pH

5 6 7 8 9

Po

ten

tia

l/ V

vs

Ag

/Ag

Cl

0.00

0.05

0.10

0.15

0.20

WT Mb

S3NH2Tyr Mb

Figure 4.7 Plot of peak potentials vs pH for WT Mb and S3NH2Tyr Mb. Proteins are immobilized on L-Cys-modified gold electrode in nitrogen purged 100 mM phosphate buffer with 10 mM KCl solutions (pH 7.0) at room temperature.

A wide variety of electrode systems have been used to explore the electrochemistry of

Mb. A comparison of some of these systems is tabulated below (Table 4.2). Similar cathodic

and anodic peak separation due to slow DET has also been reported in earlier literature. In this

study, when employing L-Cys for the gold electrode surface modification, the electrochemical

behaviour of the WT Mb and the S3NH2Tyr Mb mutant was significantly different. Since the

electrochemical reaction was quasi-reversible in nature, the formal reduction potential E°′ was

estimated from the midpoint potential E1/2 [obtained from (Epc + Epa)/2]. The WT Mb and the

immobilized S3NH2Tyr Mb mutant gave values of E1/2 between 0.080 V and 0.103 V with

respect to Ag/AgCl (3.5 M KCl) reference, respectively. These midpoint potentials of the heme

center of the WT Mb are in accord with reported values in the literature.(151, 162) The rather

large separation of the cathodic and anodic peaks indicated that DET to the protein was quite

slow.

Page 100: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

83

Table 4.2 Comparison of direct electrochemistry of Mb on various electrode systems.

Electrode E1/2 values

(V)[a]

∆Ep

(V)

Reference

Gold/L-Cys-linked with

tetraethylglycol diacrylate and

S3NH2Tyr Mb mutant

0.103 ~0.150 This work

Gold/L-Cys-WT Mb 0.080 ~0.091 This work

Gold/L-Cys-WT Mb 0.086 (151)

Gold/Homocysteine-WT Mb -0.012 ~0.246 (162)

Gold nanopyramids-WT Mb 0.210 ~0.060 (163)

Gold/azide-terminated alkane thiols-

WT Mb

-0.335 (123)

NAF/Mb/IL/PtNPs/MWCNTs/GCE[b]

~0.140 (134)

Mb-CA/GCE[c]

-0.281 ~0.102 (164)

Mb/DDAB–HIMIMPF6[d]

-0.261 ~0.044 (165)

[a]All literature values for E1/2 have been converted to Ag/AgCl (3.5 M KCl) reference electrode,

for clarity; [b]

NAF/Mb/IL/PtNPs/MWCNTs/GCE = Glassy carbon electrode modified with multi-walled carbon nanotubes (MWCNTs), followed by platinum nanoparticles (PtNPs), ionic liquids (IL) and Nafion (NAF) with WT Mb;

[c]Mb-CA/GCE = Glassy carbon electrode modified with

calcium alginate and WT Mb; [d]

Mb/DDAB–HIMIMPF6 = Glassy carbon electrode modified with didodecyldimethylammonium bromide (DDAB), 1-hexyl-3-methylimidazolium hexafluorophosphate (HIMIMPF6) and WT Mb.

The rate of heterogeneous electron transfer between the electrode and the immobilized

protein was calculated using Laviron’s method (161). The value of the transfer coefficient ( )

was determined using Eq. 2:

ln)1(

)1(ln

)1(

)1(ln

)1(

lnlnln

00

00

nF

RT

RTk

nF

nF

RTE

RTk

nF

nF

RTEE

nF

RT

RTk

nF

nF

RTE

RTk

nF

nF

RTEE

ss

pa

ss

pc

(Eq. 2)

where Eº is the standard potential, ks is the heterogeneous electron transfer rate

constant, and n = 1. The potentials for the cathodic (Epc) and anodic (Epa) peaks were plotted

against ln (v) and on analyzing the ratio of the slopes of the plots, an average value of the

Page 101: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

84

transfer coefficient, , was found to be 0.54 for the S3NH2Tyr Mb mutant, and 0.51 for the WT

Mb immobilized electrode. The heterogeneous electron transfer rate constants for immobilized

WT Mb and the S3NH2Tyr Mb mutant were determined from the following equation (Eq. 3) at

different scan rates:

log)1(

3.2logloglog)1()1log(

)1(

3.2

3.2

)1(loglog)1()1log(log

nF

RT

nF

RTk

nF

RTE

RT

EnF

nF

RTk

sp

p

s

(Eq. 3)

where ΔEp is the peak potential separation. Using the respective values of α and from

the plot of ΔEp vs log v (see Supporting Information Figure SI-6), ks was estimated to be 1.3

sec–1

and 2.3 sec–1

respectively for the immobilized S3NH2Tyr Mb mutant and WT Mb on the

chemically modified gold electrode. The S3NH2Tyr Mb mutant monolayer has slightly slower

electron transfer kinetics than the multilayered WT Mb presumably due to the varying length of

the anchoring tethers in the two cases (see Table 4.1).

Table 4.1 compares surface modification chemistries based on anchoring molecules

used for the immobilization of Mb on gold electrode surfaces and their associated ks values

reported in two previous studies (151, 162) with the results from this study. It is observed that

random immobilization of WT Mb leads to a decrease in the DET from 2.26 sec–1

to 0.93 sec–1

as the linker molecule length is increased from L-Cys (~4.75 Å) to homocysteine (~5.35 Å).

Though the theoretical length of the tether is longer (~26 Å) in the case of S3NH2Tyr Mb mutant,

it facilitates faster electron transfer compared to homocysteine. This could be due to the

tetraethylene glycol-linker providing a through-bond electron transfer environment from the

electrode to the redox-sensitive heme center of the Mb (164, 166).

Page 102: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

85

Potential /V vs. Ag/AgCl

-0.4-0.20.00.20.4

Cu

rren

t /A

-2e-4

-2e-4

-1e-4

-5e-5

0

5e-5

Au-LCys

Au-LCys-WT Mb

Au-LCys-TEGDA-S3NH2Tyr Mb

Au-Lcys-Hemin

Hemin (5 M) in solution

Figure 4.8 Comparision of immobilized Mb with hemin on modified gold electrode. CV response of hemin in solution, L-Cys modified, hemin immobilized, WT Mb and S3NH2Tyr Mb mutant immobilized gold electrode in nitrogen-purged 100 mM phosphate buffer with 10 mM KCl (pH 7.0) at room temperature and at a potential scan rate of 0.1 Vsec

–1.

An important aspect of the heme bleaching from the protein immobilized electrode

suface was carefully investigated for both the S3NH2Tyr Mb mutant and the WT Mb protein. The

redox responses of the free hemin (5 µM) in solution and when immobilized on the amine-

functionalized gold electrode surface were observed to be quite different from those of the

S3NH2Tyr Mb and the WT Mb-bound surface (Figure 4.6). From these data, it can be inferred

that heme bleaching was absent from both the S3NH2Tyr Mb mutant and the WT Mb

immobilized electrodes under the above mentioned experimental conditions.

Page 103: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

86

4.3.3 Catalytic studies

Mb has often been utilized to explore the monooxygenase activity of heme proteins in

presence of H2O2, in order to investigate the P450 catalytic shunt-pathway. A common

substrate used in such studies is thianisole, which can be catalytically oxidized to its sulfoxide

by high valent ferryl-porphyrin-π-cation radical species (also known as Compound I) of Mb.

Hence, electrocatalytic conversion of thioanisole to its oxidized form provides an ideal

comparison platform for the binding site orientation in these two modes of immobilization.

Dioxygen was bubbled into the solution and bulk electrolysis was carried out for 2 hr with the

covalently immobilized S3NH2Tyr Mb mutant and the WT Mb (Table 4.3).

Table 4.3 Electrocatalytic conversion of thioanisole to its oxidized form and turnover frequency

(TOF) using bare, multilayered WT Mb-immobilized and monolayered S3NH2Tyr Mb-immobilized Au electrodes.

Unreacted

thioanisole (%)

Thioanisole

sulfoxide

(%)

TOF for the oxidized

products (sec–1

)

Bare electrode 86 14

WT Mb 13 87 1.9 × 103

S3NH2Tyr Mb 19 81 1.5 × 103

The GC results demonstrated that 87% conversion of the thioanisole to its oxidized

form had taken place for the WT Mb immobilized electrode, while for the S3NH2Tyr Mb mutant,

81% conversion was obtained. A reduced reaction time (1 hr) did not yield sufficient product

formation in comparison to that of 2 hr catalytic reaction. A control experiment was also carried

out for the electrocatalytic oxidation of thioanisole in the presence of bare Au. Only 14%

conversion of the thioanisole to its sulfoxide was observed in this case after 2 hr. Considering

Page 104: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

87

the amount of electro-active protein covalently attached onto the surface from Eq. 1, the

turnover frequency (TOF) for the WT Mb was 1.9 × 103 sec

–1. Similarly, the TOF for the

S3NH2Tyr Mb mutant was 1.5 × 103 sec

–1. Significantly, the comparable catalytic activity

observed for the multilayered WT Mb and the monolayered S3NH2Tyr Mb mutant reiterates the

importance of orientation of the active sites of both the proteins. The random orientation of

binding site in the multilayered protein leads to loss of catalytic activity (considering the greater

number of proteins on the surface), than the monolayered mutant S3NH2Tyr Mb. Proper

orientation of the heme active site in the monolayered S3NH2Tyr Mb mutant assisted the

catalytic and redox-activity of the protein, when covalently immobilized onto the modified gold

electrode surface.

4.3.4 Microarray studies

Functionalization of glass surface with polyethylene glycol (PEG) was done by using the

methods as previously described (167). To attach S3NH2Tyr Mb on PEG linker, Diels–Alder

reaction was used in mild conditions, such as in water (168). Since the protein will bind only

through its unnatural amino acid, we have control of the active site in mutants. The immobilized

protein on glass surface was analyzed by AFM, in which monomeric S3NH2Tyr Mb showed

expected dimensions of height and width (Figure 4.3) based on crystal structure.

4.3.4.1 Preparation of functional protein microarrays

A library of five proteins was printed on a single slide, to determine if our technique can

be used for microarray studies (Figure 4.7). In order to understand orientation of the protein

arrays and selective protein-protein interaction, we allowed HiLyte 647 fluorophore-conjugated

anti-6×His tag rabbit IgG to bind with the proteins that were spotted on the surface. S3NH2Tyr

Mb and T365 (3NH2Tyr P450 BM3) (Figure 4.7) were the only two proteins that show surface-

exposed 6×His-tag chains when we observed the site of immobilization. Thus these were the

Page 105: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

88

two proteins that showed the direct and efficient binding with IgG. However, all other proteins

except the control were attached to the surface after the tagging reaction, as they were visible in

coomassie blue staining. This experiment confirmed the interaction between IgG and the protein

could be generated in a specific manner as well as control over the orientation of the protein.

Page 106: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

89

Page 107: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

90

Figure 4.9 A microarray of five proteins on a single slide displays. (a) T365 (3NH2Tyr) P450 BM3. (b) P450 BM3 control without NaIO4 (control shows that printed proteins were detached from the surface after washing). (c) T73 (3NH2Tyr) CA. (d) D125 (3NH2Tyr) CA. (e) D133 (3NH2Tyr) EGFP. (f) S3 (3NH2Tyr) Mb. Column 2 displays an image of excitation at 649 nm and emission at 666 nm.

Page 108: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

91

Page 109: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

92

Figure 4.10 Spectroscopic characterization of high spin, low spin and ligand complexes of WT and mutant Mb. Electronic absorption spectra of (A) ferric and ferrous, (B) CO, (C) NO, (D) oxyferrous, (E) cyanoferric and (F) N3

– complexes of WT Mb and S3NH2Tyr Mb.

The spectra were taken at 4 °C and the samples were examined in 100mM phosphate buffer at pH 7.0.

Page 110: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

93

4.3.5 Ligand binding studies

To understand the effect of different ligands upon replacement of residues which are

away from the active heme center of the protein, we have replaced the serine 3 (S3) with

3NH2Tyr, a redox amino acid. Figure 4.8 clearly indicates that S3NH2Tyr Mb protein behaves

more or less similar to that of WT Mb with respect to ligand-binding studies. Since position 3 is

quite distant from the heme center, it has almost no role in influencing the electronic density of

the Asheme center. As position 3 is quite away, it did not play a major role in determining the

ligand-metal charge transfer, metal-ligand charge transfer, and in π backbonding (104, 119).

We did not observe significant difference in the electron absorption spectra of mutant protein as

compared to WT Mb (15, 31).

4.4. Conclusion

Though, previous research groups have observed facile electron transfer using specific

organic molecules as promoters, no prior studies were reported using mutant protein that

utilizes its unnatural amino acid moiety to specifically immobilize onto the electrode surface. In

this chapter, I report monolayer and multilayer immobilization of Mb on to chemically-modified

gold electrode surfaces using two unique immobilization techniques as described above.

Further, electrocatalysis of thioanisole oxidation was carried out successfully with both the

protein immobilized electrode cases, albeit at variant facility. These results underline that the

S3NH2Tyr Mb mutant monolayer exhibits well-defined catalytic and electro-activity because of

proper orientation of its heme active site, in comparison to the random multilayered WT Mb

case.

To investigate protein-protein interactions, five separate proteins P450 BM3, Mb,

enhanced green fluorescent protein (EGFP), HRP, and CA have been covalently attached onto

a solid support and analyzed. Functional protein microarray concept development was

confirmed by a catalytic activity designed assay using spectroscopic characterization. This

Page 111: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

94

concept developed microarray will bring novelty in the field of drug discovery and biomedical

and proteomic research. The ligand binding studies showed that the S3 position being quite

away from the active heme center, does not affect the metal-ligand binding to a greater extent.

Page 112: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

95

Chapter 5

ELECTRONIC NATURE INVESTIGATION OF HEME CENTER BY MODIFYING PROXIMAL AND DISTAL BINDING SITE ENVIRONMENT OF SPERM WHALE MYOGLOBIN WITH

ELECTRON RICH RESIDUES

5.1 Introduction

The heme group is the most common prosthetic group in the metalloproteins (1). The

iron center, porphyrin, and axial ligand constitute the three covalently linked integral

components of a heme protein. In the heme proteins, a wide variety of porphyrines are present

such as heme a, heme b, heme c, heme d, heme d1, heme o, heme P460, chloroheme, and

siroheme. Among the globins and cytochrome, heme b and heme c are the most common

(Figure 5.1). A widely studied example is Mb (sperm whale), a small protein with 153 amino

acids and molecular weight of 17.5 kD, with oxygen storage as its main function in vertebrates

(2, 14, 169, 170). The presence of different varieties of amino acids around the binding site has

always been a matter of interest for the understanding of heme ligand interaction and its

catalytic activity (169, 170). With the tool of site directed mutagenesis divers, residues can be

introduced to the proteins, and complexes formed with different ligands can be investigated.

Among the heme protein, various axial ligands such as His, Cys, Met, Tyr, and Lys are found

and they play a crucial role in their properties (14, 22). His present at 64 position plays a major

role in stabilizing the ligand adduct by forming bonds to the ligands attached to the heme

moiety. It has been proposed that with open and closed confirmation distal His can act like a

gate for ligand adducts (1, 15, 29, 171, 172).

Figure 5.2 B shows the details of amino acid residues around the heme center in sperm

whale Mb. It is also believed that the size of certain residues also contributes significantly to

determining the heme ligand complex stability. But the role played by the electronic nature

around heme center is not clearly understood. The introduction of noncannonical amino acids

with electron rich functional groups such as pNO2Phe, will allow us to investigate the electronic

nature of heme center, and its effect on ligand (CO, NO, O2, CN–, and N3

–) binding to a greater

Page 113: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

96

extent. For our further understanding of interaction of CO, NO, O2, N3–, and CN

− with Mb as a

model for heme protein, I have created mutations at its distal and proximal sites (15). By site

directed mutagenesis we have replaced the His with pNO2Phe at His 64 and His 93 positions

and compared the interaction of different ligands with these mutants, as well as to WT Mb (15,

88).

Figure 5.1 Structures of heme b and heme c.

Page 114: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

97

Figure 5.2 Schematic representations of WT and mutants Mb. (A) Overall structure of WT Mb. (B) enlarged binding site of WT Mb, (C) structure of H64pNO2Phe and (D) structure of H93pNO2Phe mutants.

5.2 Experimental procedure

5.2.1 Chemicals

The gasses (O2, CO, and N2) have been purchased from Air Liquide, USA while

pNO2Phe, sodium azide, potassium cyanide, and Na2S2O4 were purchased from Sigma-Aldrich

Page 115: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

98

USA. All chemicals were of analytical grade and have been used without any further purification

(173).

5.2.2 Preparation of WT, H64pNO2Phe and H93pNO2Phe Mb mutant constructs

The WT Mb expression constructs H64pNO2Phe and H93pNO2Phe Mb gene

expression vector and aminoacyl tRNA synthetase (aatRNA S) plasmids were donated by Dr.

Peter Schultz (The Scripps Research Institute, La Jolla, CA USA). The H64pNO2Phe and

H93pNO2Phe Mb expression vector were co-transformed with tRNA synthetase separately in

DH10B E.coli. The bacterial colonies which are double antibiotic (ampicillin and tetracycline)

resistant were picked, grown, and the cell stocks were stored at –80 °C prior to the start of

bacterial cell culture for protein purification (15).

5.2.3 Purification and analysis of WT Mb, H64pNO2Phe and H93pNO2Phe Mb

The H64pNO2Phe Mb and H93pNO2Phe Mb were expressed in E. coli bacteria which

were grown in GMML containing 5% LB media and suitable antibiotics (ampicillin and

tetracycline). Both the WT and mutated (H64pNO2Phe and H93pNO2Phe) Mb proteins were

induced, expressed, purified, and analyzed as described in chapter 2.

Page 116: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

99

Figure 5.3 Coomassie-stained SDS-PAGE analysis of expression of WT, H64pNO2Phe and H93pNO2Phe mutants Mb. Lane 1 expressed WT Mb, Lane 2 H64pNO2Phe mutant Mb, Lane 3 Molecular weight standards and Lane 4 H93pNO2Phe mutant Mb. 5.2.4 Electronic absorption spectroscopy

UV-visible electronic absorption spectra of WT Mb proteins and the mutant H64pNO2

and H93pNO2 Mb proteins were taken using Varian Cary 50 Bio UV-visible spectrophotometer.

The concentrations of proteins were determined from the absorption spectrum of the protein,

using the molar extinction coefficient determined by the heme chromatogen method (96).

Page 117: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

100

5.2.5 Preparation of deoxyferrous Mb

The WT Mb and mutants Mb proteins were taken in their respective airtight cuvettes

containing 0.1 M potassium phosphate buffer, pH 7.0. The N2 gas was passed for ~2 hr at 4 °C

to degas the sample. The minimal amount of Na2S2O4 (in µL) was added from the stock of 20

mg/mL and the electronic absorption spectra were recorded by Varian Cary 50 Bio UV-visible

spectrophotometer (15).

5.2.6 Preparation of oxyferrous complex

The oxyferrous complexes were prepared in a chest freezer at −35 to −45 °C. The

protein sample was placed in a 100 mM potassium phosphate buffer (pH 7.0), which contained

65% glycerol (v/v). The ferric protein was first degassed with N2 gas for 2 hrs. Then it was

reduced to deoxyferrous by addition of Na2S2O4 (20 mg/mL stock) under N2 atmosphere in a

sealed cuvette at 4 °C. Pre-cooled O2 gas was bubbled into the cuvette for 60 sec and the UV-

visible spectra were recorded (15, 31, 40).

5.2.7 CO and NO complex preparation

The ferrous-CO adducts were generated by gentle bubbling of CO in deoxyferrous

enzymes for 30 sec at 4°C in 0.1 M potassium phosphate buffer pH 7.0. The ferrous-NO

complexes were generated by micoliter addition of buffer saturated with NO gas in deoxyferrous

enzymes under N2 at 4 °C in 0.1 M potassium phosphate buffer pH 7.0. The saturated buffer

was prepared by gentle bubbling of NO gas in a sealed cuvette containing 0.1 M potassium

phosphate buffer pH 7.0 for 30 min at room temperature (15, 31, 32, 40).

5.2.8 N3– and CN

– complex preparation

Page 118: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

101

WT Mb and mutants Mb N3– complexes were formed by µL addition of NaN3 solution

from 40 mM stock solution. The NaN3 stock solution and protein were in 100 mM potassium

phosphate buffer pH 7.0 and the temperature was kept at 4 °C. The cyanoferric adducts were

prepared from the deoxyferric enzymes by addition of minimal volumes (µL) of a 1 M KCN stock

solution, prepared in 100 mM potassium phosphate buffer pH 7.0. The deoxyferric enzymes

were prepared by bubbling of N2 gas in the ferric enzymes for at least 30 min.

5.3 Results and discussion

Here we studied the ferrous and ferric electronic absorption spectra of Mb and its

mutants (H64pNO2Phe Mb and H93pNO2Phe) in absence and presence of exogenous ligands

such as CO, NO, O2, N3–, and CN

– using UV-vis spectroscopy. The electronic absorption

spectra of the ferric form of the enzyme showed that there are significant differences in their

character, particularly at 550-650 nm (Figure 5.4). The peaks around 539, 578, and 628 nm in

ferric and around 662 nm in ferrous enzyme were not prominent in mutants when compared to

the WT Mb. Due to the presence of the electron rich functional group (pNO2Phe), the Sorets

around 409 nm in ferric and around 430 nm in ferrous were a little sharper in case of mutant

enzymes (Figures 5.4 and 5.5).

Page 119: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

102

Figure 5.4 Characterization of ferric WT and mutants Mb. Electronic absorption spectra of the H64pNO2Phe (blue dashed-dot), H93pNO2Phe (black solid line) and WT (red dashed line) of ferric Mb enzymes. The spectra were recorded in 100 mM potassium phosphate buffer, pH 7.0 at 4 °C with 5 μM protein.

Page 120: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

103

Figure 5.5 Deoxyferrous electronic absorption spectra of WT, H64pNO2Phe and H93pNO2Phe mutant Mb. WT Mb (red dashed line), H64pNO2Phe (blue dashed-dot) and H93pNO2Phe Mb mutant (black solid line). The spectra were taken at 4 °C and the samples were examined in 100mM phosphate buffer at pH 7.0.

5.3.1 Ferrous-CO, ferrous-NO and ferrous O2 complexes of WT, H64pNO2Phe and H93pNO2Phe Mb

To understand the effect of different ligands upon replacement of distal and proximal

His and electronic nature of the heme center, I have investigated the ferrous-XO (X= C, N, O)

complexes of Mb and its mutants. As XO molecules have vacant π orbitals which closely

matched with filled dπ orbitals of the Fe (II) ion of porphyrin, it makes the heme group

electronically more favorable to bind to CO, NO and O2. Furthermore, this kind of arrangement

was found to be optimal for the Fe-XO π-backbonding. The backbonding was responsible for

shortening (strengthening) the Fe-X bond and lengthening (weakening) of the X-O bond

(Figures 5.6 and 5.7) (40, 174-176).

Page 121: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

104

Figure 5.6 The heme carbonyl complex showing dπ-pπ* backbonding.

Figure 5.7 Showing presence of electron rich functional group (NO2−) at distal position.

Page 122: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

105

Table 5.1 The electronic absorption spectral features of the oxy, carbonyl, NO, CN−, and N3

− complexes with H64pNO2Phe Mb,

H93pNO2Phe Mb mutants and WT Mb.

H64pNO2Phe

Soret (nm)

Visible (nm)

H93pNO2Phe

Soret (nm)

Visible (nm)

WT Mb

Soret (nm)

Visible (nm) (References)

Ferric 408.9 Ferric 408.9 635 Ferric 409 505; 539; 578; 628; 675

(175) Deoxyerrous 430 558 Ferrous 433 635 Ferrous 431 556; 662

(175)

Fe3+

- CN– 422.9 537; 576 423 536.9 420 542; 642.2

(175) Fe

3+- N3

– 422 541; 576 421 536; 571 416 534; 583;

636; 661

Fe2+

-CO 424 539; 573 422.9 542; 577 422 540; 570; 649; 611 (10)

Fe2+

-O2 419.9 542; 580 416.9 541.5; 579.6

416 540; 581; 668 (15)

Fe2+

-NO 419 545, 577 419 546, 580 420 547, 581, (40)

Page 123: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

106

Ferrous-CO complexes of the H64 and H93 pNO2Phe have shown higher intensity of

absorbance compared to ferrous-NO and ferrous–O2 complexes (Figure 5.8). This may be due

to Fe-CO being linear adduct and both of its π orbitals have empty shells. It allows dπ-π

orbitals to overlap in a perpendicular direction, which results in a prominent overlapping, and

more backbonding giving rise to sharper Soret (119). However under the similar conditions, NO

and O2, occupies one and two π electrons, respectively in their π orbitals. In order to

accommodate any π-antibonding interaction, the NO and O2 adducts have to bend, which

further lowers the possibility of overlapping and backbonding. This leads to less prominent Soret

in NO and O2 as compare to CO (Figure 5.8, 5.9 and 5.10). It is noteworthy that there were

significant differences within the XO adducts of different proteins’ electronic spectra (Table 5.1).

When axial His H93 attached to heme center, was replaced by pNO2Phe (an electron rich

functional group), the sharper Soret was recorded due to stretching one dπ-π backbonding

electron transition via push effect The pNO2Phe increases the electron density near the Fe (II)

center, which enhances the metal-ligand charge transfer and backbonding. Similar results were

not observed when the distal His 64 was replaced by pNO2Phe. The distal pNO2Phe probably

increases the electron density around the CO orbitals which favors ligand-metal charge transfer

and lowers the backbonding. Since O2 has two π electrons, reverse characteristics have been

observed in the oxyferrous complex (Figure 5.10). The different enzymes show different peaks

in 550-700 nm regions (Table 5.1), which explains that they also have diverse, features in

visible region (3, 176).

Page 124: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

107

Figure 5.8 Comparative studies of carbonyl complexes of WT, H64pNO2Phe, and H93pNO2Phe. Electronic absorption spectra of CO complex of WT Mb (red dashed line), H64pNO2Phe (blue dashed-dot) and H93pNO2Phe Mb mutant (black solid line). The spectra were taken at 4 °C and the samples were examined in 100mM phosphate buffer at pH 7.0.

Page 125: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

108

Figure 5.9 Comparative studies of NO complexes of WT, H64pNO2Phe, and H93pNO2Phe. Electronic absorption spectra of NO complex of WT Mb (red dashed line), H64pNO2Phe (blue dashed-dot) and H93pNO2Phe Mb mutant (black solid line). The spectra were taken at 4 °C and the samples were examined in 100mM phosphate buffer at pH 7.0.

Page 126: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

109

Figure 5.10 Characterization of oxyferrous complexes of WT, H64pNO2Phe, and H93pNO2Phe Mb. Electronic absorption spectra of WT Mb oxyferrous (red dashed line), H64pNO2Phe mutant Mb oxyferrous (blue dashed-dot) and H93pNO2Phe mutant Mb oxyferrous (black solid line). The spectra were taken at −35 to −45 °C and the samples were examined in 60% glycerol, 100mM phosphate buffer at pH 7.0.

The stability of XO adducts are dictated by hydrogen bonding between the XO and

distal protein moiety (figure 5.11). In WT Mb at the 64 position, His is present, which is primarily

responsible for the H-bonding, hence the stability of XO adducts (176). When I replaced the His

with pNO2Phe, the possibility of H-bonding at distal pocket was reduced, which lowers stability

of complex. Furthermore, the electron rich oxygen allowed more electronic distribution, which

led to prominent ligand to metal charge transfer as seen in uv-vis spectrum. The replacement of

the proximal His 93 with pNO2Phe led to increased electron density, and backbonding was

more prominent around XO orbital; it helped in forming the H-bond with distal His. Thus I

Page 127: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

110

conclude that when we replaced the axial His with the pNO2Phe, the XO adducts were more

stable than in other cases.

Figure 5.11 Proposed structure of (A) Fe (II) O2, (B) Fe (II) CO and (C) Fe (II) NO.

5.3.2 Ferric-cyanide and ferric-azide complexes of WT and H64pNO2Phe and H93pNO2Phe

mutants of Mb

Characterization of anionic ligand adducts such as CN– and N3

– to ferric WT Mb and

mutant Mb were important to understand how the electronic nature affects heme center. It gives

us the idea of the impact of protein environment on heme center. Ligand to metal charge

transfer are ideal for metals in high oxidation states such as Fe3+

that are bound to electron rich,

low electronegativity ligands such as N3– and CN

– (15, 175-177). The charge transfer from

ligand to metal will cause the increase in Soret, but due to lack of backbonding, it was not as

Page 128: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

111

prominent as in the case of the CO adduct. The charge transfer from ligand to heme center

made it a low spin complex; the red shift was observed to high energy (Figures 5.12 and 5.13).

As CN– is a stronger field ligand, the Soret was less sharp in the ferrycyanide complex .

The introduction of electron rich oxygen in pNO2Phe at axial and distal positions has a

significant impact on the electronic density of the heme center. When we replaced distal His

with pNO2Phe in electron density around CN– and N3

– ligands, orbitals increased.

Consequently, there was more ligand-metal charge transfer, resulting in an increase in Soret

and red shift. While we replaced axial His with pNO2Phe, the Fe center was more electron rich,

which caused the red shift (λmax 423, 436.9, 437.4, and 576). There was less possibility of metal

to ligand charge transfer and backbonding, as the ligand was electron rich and its orbitals are

filled, and therefore no significant increase in Soret (119). The adducts also showed quite a

distinct feature in their 550-700 nm region (Table 5.1), which supports that the heme

environment has a significant role on heme proteins in the determination of their catalytic and

ligand binding properties.

Page 129: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

112

Figure 5.12 Comparative studies of CN

– complexes of WT, H64pNO2Phe, and H93pNO2Phe

Mb. Electronic absorption spectra of ferric CN– complex of WT Mb (red dashed line),

H64pNO2Phe (blue dashed-dot) and H93pNO2Phe Mb mutant (black solid line). The spectra were taken at 4 °C and the samples were examined in 100mM phosphate buffer at pH 7.0.

Page 130: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

113

Figure 5.13 Characterization of N3

– complexes of WT, H64pNO2Phe, and H93pNO2Phe Mb.

Electronic absorption spectra of ferric N3– complex of WT Mb (red solid line), H64pNO2Phe

(blue dashed-dot) and H93pNO2Phe Mb mutant (black solid line). The spectra were taken at 4 °C and the samples were examined in 100mM phosphate buffer at pH 7.0.

The H-bonding also plays a significant role in the stability of CN– and N3

– adducts

(Figures 5.14 and 5.15). Any residue that strengthens the H-bonding will make a stronger

adduct and vice versa. In this case, as pNO2Phe reduces the possibility of H-bonding at the

distal pocket, it leads to weaker adducts. But the size of the residues also plays a significant

role in holding the ligands by not allowing them to leave the binding site environment.

Page 131: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

114

Figure 5.14 Two canonical forms of N3

– bound to heme iron of WT Mb and H64pNO2Phe Mb

mutant.

Figure 5.15 Two canonical forms of CN

– bound to heme iron of WT Mb and H64pNO2Phe Mb

mutant.

Page 132: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

115

5.3 Conclusion

To summarize, the importance and significance of electron rich functional groups on the

electronic nature of heme center had been explored. It has been found that the axial His

attached to the heme center plays a crucial role in dictating the electron cloud near the heme

center. When the axial heme is replaced by an electron rich residue like pNO2Phe, the electron

density was higher near heme center, which contributes to higher energy and red shift of the

spectra. This study also concludes that the oxidation states of metal centers and the natures of

ligand (electron rich or electron deficient) play an important role in determining the backbonding

and direction of charge transfer (from metal to ligand or ligand to metal). The redox nature and

size of the distal residue also has a high impact on determining the stability of the ligand

adducts. It is well known that the H-bonding plays an important role in the stability of ligand

adducts, but what role the size of noncanonical (such as pNO2Phe) residues play in the stability

of ligand adducts is uncertain.

Page 133: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

116

Page 134: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

117

REFERENCES

1. Montelanno, P. R. O. d., (Ed.) (2008) Cytochrome P450: Structure, Mechanism, and

Biochemistry, Third ed., Springer-Verlag New York, LLC, New York.

2. Bertini, I., Sigel, A., Sigel, H., (Ed.) (2001) Handbook on metalloproteins, Marcel

Dekker, Inc., New York.

3. Spiro, T. G., Soldatova, A. V., and Balakrishnan, G. (2013) CO, NO and O-2 as

vibrational probes of heme protein interactions, Coord. Chem. Rev. 257, 511-527.

4. Matsui, T., Ozaki, S., and Watanabe, Y. (1997) On the formation and reactivity of

compound I of the His-64 myoglobin mutants, J. Biol. Chem. 272, 32735-32738.

5. Bates, D. M., Popescu, C. V., Khoroshilova, N., Vogt, K., Beinert, H., Munck, E., and

Kiley, P. J. (2000) Substitution of leucine 28 with histidine in the Escherichia coli

transcription factor FNR results in increased stability of the [4Fe-4S](2+) cluster to

oxygen, J. Biol. Chem. 275, 6234-6240.

6. Denisov, I. G., Makris, T. M., and Sligar, S. G. (2002) Formation and decay of

hydroperoxo-ferric heme complex in horseradish peroxidase studied by cryoradiolysis,

J. Biol. Chem. 277, 42706-42710.

7. Tatoli, S., Zazza, C., Sanna, N., Palma, A., and Aschi, M. (2009) The role of Arginine 38

in horseradish peroxidase enzyme revisited: A computational investigation, Biophys.

Chem. 141, 87-93.

8. Coulter, E. D., Cheek, J., Ledbetter, A. P., Chang, C. K., and Dawson, J. H. (2000)

Preparation and initial characterization of the compound I, II, and III states of iron

methylchlorin-reconstituted horseradish peroxidase and myoglobin: models for key

intermediates in iron chlorin enzymes, Biochem. Biophys. Res. Commun. 279, 1011-

1015.

9. Rohlfs, R. J., Mathews, A. J., Carver, T. E., Olson, J. S., Springer, B. A., Egeberg, K.

D., and Sligar, S. G. (1990) The effects of amino acid substitution at position E7

(residue 64) on the kinetics of ligand binding to sperm whale myoglobin, J. Biol. Chem.

265, 3168-3176.

10. Adachi, S., Nagano, S., Ishimori, K., Watanabe, Y., Morishima, I., Egawa, T., Kitagawa,

T., and Makino, R. (1993) Roles of proximal ligand in heme proteins: replacement of

proximal histidine of human myoglobin with cysteine and tyrosine by site-directed

Page 135: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

118

mutagenesis as models for P-450, chloroperoxidase, and catalase, Biochemistry 32,

241-252.

11. RodriguezLopez, J. N., Smith, A. T., and Thorneley, R. N. F. (1996) Recombinant

horseradish peroxidase isoenzyme C: The effect of distal haem cavity mutations

(His42->Leu and Arg38->Leu) on compound I formation and substrate binding, J. Biol.

Inorg. Chem. 1, 136-142.

12. Frauenfelder, H. (2010) Myoglobin as an example of protein complexity, Chem. Phys.

375, 612-615.

13. Cohen, F. E., and Sternberg, M. J. E. (1980) Use of Chemically Derived Distance

Constraints in the Prediction of Protein-Structure with Myoglobin as an Example, J. Mol.

Biol. 137, 9-22.

14. Brunori, M., Bourgeois, D., and Vallone, B. (2004) The structural dynamics of

myoglobin, J. Struct. Biol. 147, 223-234.

15. Du, J., Sono, M., and Dawson, J. H. (2011) The H93G myoglobin cavity mutant as a

versatile scaffold for modeling heme iron coordination structures in protein active sites

and their characterization with magnetic circular dichroism spectroscopy, Coord. Chem.

Rev. 255, 700-716.

16. Yang, H. J., Matsui, T., Ozaki, S., Kato, S., Ueno, T., Phillips, G. N., Fuku-Zumi, S., and

Watanabe, Y. (2008) Molecular engineering of myoglobin: Influence of residue 68 on

the rate and the enantioselectivity of oxidation reactions catalyzed by H64D/V68X

myoglobin (vol 42, pg 10174, 2003), Biochemistry 47, 2700-2700.

17. Pfister, T. D., Ohki, T., Ueno, T., Hara, I., Adachi, S., Makino, Y., Ueyama, N., Lu, Y.,

and Watanabe, Y. (2005) Monooxygenation of an aromatic ring by F43W/H64D/V68I

myoglobin mutant and hydrogen peroxide - Myoglobin mutants as a model for P450

hydroxylaation chemistry, J. Biol. Chem. 280, 12858-12866.

18. Sato, H., Hayashi, T., Ando, T., Hisaeda, Y., Ueno, T., and Watanabe, Y. (2004)

Hybridization of modified-heme reconstitution and distal histidine mutation to

functionalize sperm whale-myoglobin, J. Am. Chem. Soc. 126, 436-437.

19. Yang, H. J., Matsui, T., Ozaki, S., Kato, S., Ueno, T., Phillips, G. N., Fukuzumi, S., and

Watanabe, Y. (2003) Molecular engineering of myoglobin: Influence of residue 68 on

the rate and the enantioselectivity of oxidation reactions catalyzed by H64D/V68X

myoglobin, Biochemistry 42, 10174-10181.

Page 136: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

119

20. Watanabe, Y., and Hayashi, T. (2005) Functionalization of Myoglobin, Prog. Inorg.

Chem. 54, 449-493.

21. Kato, S., Yang, H. J., Ueno, T., Ozaki, S., Phillips, G. N., Fukuzumi, S., and Watanabe,

Y. (2002) Asymmetric sulfoxidation and amine binding by H64D/V68A and H64D/V68S

Mb: Mechanistic insight into the chiral discrimination step, J. Am. Chem. Soc. 124,

8506-8507.

22. Hara, I., Ueno, T., Ozaki, S., Itoh, S., Lee, K., Ueyama, N., and Watanabe, Y. (2001)

Oxidative modification of tryptophan 43 in the heme vicinity of the F43W/H64L

myoglobin mutant, J. Biol. Chem. 276, 36067-36070.

23. Herold, S., Matsui, T., and Watanabe, Y. (2001) Peroxynitrite isomerization catalyzed

by His64 myoglobin mutants, J. Am. Chem. Soc. 123, 4085-4086.

24. Ozaki, S., Hara, I., Matsui, T., and Watanabe, Y. (2001) Molecular engineering of

myoglobin: The improvement of oxidation activity by replacing Phe-43 with tryptophan,

Biochemistry 40, 1044-1052.

25. Roach, M. P., Ozaki, S., and Watanabe, Y. (2000) Investigations of the myoglobin

cavity mutant H93G with unnatural imidazole proximal ligands as a modular peroxide O-

O bond cleavage model system, Biochemistry 39, 1446-1454.

26. Matsui, T., Ozaki, S., and Watanabe, Y. (1999) Formation and catalytic roles of

compound I in the hydrogen peroxide-dependent oxidations by His64 myoglobin

mutants, J. Am. Chem. Soc. 121, 9952-9957.

27. Tada, T., Watanabe, Y., Matsuoka, A., Ikeda- Saito, M., Imai, K., Yukio, N., and

Shikama, K. (1998) African elephant myoglobin with an unusual autoxidation behavior:

comparison with the H64Q mutant of sperm whale myoglobin, Biochim. Biophys. Acta.

M 1387, 165-176.

28. Dawson, J. H. (2011) His93Gly Myoglobin Cavity Mutant: A Versatile Scaffold for

Modeling Heme Protein Active Sites. Applications to Novel Heme Transport and Redox

Proteins, Biophys. J. 100, 379-379.

29. Du, J., Perera, R., and Dawson, J. H. (2011) Alkylamine-Ligated H93G Myoglobin

Cavity Mutant: A Model System for Endogenous Lysine and Terminal Amine Ligation in

Heme Proteins such as Nitrite Reductase and Cytochrome f, Inorg. Chem. 50, 1242-

1249.

Page 137: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

120

30. Du, J., Sono, M., and Dawson, J. H. (2011) Ferric His93Gly myoglobin cavity mutant

and its complexes with thioether and selenolate as heme protein models, J. Porphyr.

Phthalocya. 15, 29-38.

31. Perera, R., Sono, M., Kinloch, R., Zhang, H. M., Tarasev, M., Im, S. C., Waskell, L., and

Dawson, J. H. (2011) Stabilization and spectroscopic characterization of the dioxygen

complex of wild-type cytochrome P4502B4 (CYP2B4) and its distal side E301Q, T302A

and proximal side F429H mutants at subzero temperatures, Biochim. Biophys. Acta.

1814, 69-75.

32. Perera, R., Sono, M., Voegtle, H. L., and Dawson, J. H. (2011) Molecular basis for the

inability of an oxygen atom donor ligand to replace the natural sulfur donor heme axial

ligand in cytochrome P450 catalysis. Spectroscopic characterization of the Cys436Ser

CYP2B4 mutant, Arch. Biochem. Biophys. 507, 119-125.

33. Huang, X., Wang, C. X., Celeste, L. R., Lovelace, L. L., Sun, S. F., Dawson, J. H., and

Lebioda, L. (2012) Complex of myoglobin with phenol bound in a proximal cavity, Acta.

Crystallogr. 68, 1465-1471.

34. Du, J., Sono, M., and Dawson, J. H. (2008) The proximal and distal pockets of the

H93G myoglobin cavity mutant bind identical ligands with different affinities:

Quantitative analysis of imidazole and pyridine binding, J.Spectroscopy 22, 123-141.

35. Qin, J., Perera, R., Lovelace, L. L., Dawson, J. H., and Lebioda, L. (2006) Structures of

thiolate- and carboxylate-ligated ferric H93G myoglobin: Models for cytochrome P450

and for oxyanion-bound heme proteins, Biochemistry 45, 3170-3177.

36. Perera, R., and Dawson, J. H. (2004) Modeling heme protein active sites with the

his93gly cavity mutant of sperm whale myoglobin: complexes with nitrogen-, oxygen-

and sulfur-donor proximal ligands, J. Porphyr. Phthalocya. 8, 246-254.

37. Perera, R., Sono, M., and Dawson, J. H. (2003) His93Gly cavity mutant of sperm whale

myoglobin as a template for ferric, ferrous, and ferryl heme states of mixed ligand

complexes., Biochemistry 42, 8649-8649.

38. Dawson, J. H., Pond, A. E., and Roach, M. P. (2002) H93G myoglobin cavity mutant as

versatile template for modeling heme proteins: Magnetic circular dichroism studies of

thiolate- and imidazole-ligated complexes, Biopolymers 67, 200-206.

Page 138: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

121

39. Dawson, J. H., Pond, A. E., Roach, M. P., Perera, R., Dasgupta, A., Thomas, M. R.,

and Boxer, S. G. (2001) Modeling ferrous, ferric and ferryl heme states using His93Gly

myoglobin and related heme iron systems, J. Inorg. Biochem. 86, 39-39.

40. Pond, A. E., Roach, M. P., Thomas, M. R., Boxer, S. G., and Dawson, J. H. (2000) The

H93G myoglobin cavity mutant as a versatile template for modeling heme proteins:

Ferrous, ferric, and ferryl mixed-ligand complexes with imidazole in the cavity, Inorg.

Chem. 39, 6061-6066.

41. Pond, A. E., Roach, M. P., Sono, M., Rux, A. H., Franzen, S., Hu, R., Thomas, M. R.,

Wilks, A., Dou, Y., Ikeda-Saito, M., de Montelano, P. R. O., Woodruff, W. H., Boxer, S.

G., and Dawson, J. H. (1999) Assignment of the heme axial ligand(s) for the ferric

myoglobin (H93G) and heme oxygenase (H25A) cavity mutants as oxygen donors

using magnetic circular dichroism, Biochemistry 38, 7601-7608.

42. Das, T. K., Franzen, S., Pond, A., Dawson, J. H., and Rousseau, D. L. (1999)

Formation of a five-coordinate hydroxide-bound heme in the His93Gly mutant of sperm

whale myoglobin, Inorg. Chem. 38, 1952-1953.

43. Roach, M. P., Franzen, S., Pang, P. S. H., Boxer, S. G., Woodruff, W. H., and Dawson,

J. H. (1997) Thiolate adducts of cavity mutant myoglobin H93G as models for

cytochrome P450, J. Inorg. Biochem, 67. 134-134.

44. Wang, L., Brock, A., Herberich, B., and Schultz, P. G. (2001) Expanding the genetic

code of Escherichia coli, Science 292, 498-500.

45. Budisa, N. (2004) Prolegomena to future experimental efforts on genetic code

engineering by expanding its amino acid repertoire, Angew. Chem. Int. Ed. Engl. 43,

6426-6463.

46. Hendrickson, T. L., de Crecy-Lagard, V., and Schimmel, P. (2004) Incorporation of

nonnatural amino acids into proteins, Annu. Rev. Biochem. 73, 147-176.

47. Budisa, N., and Pal, P. P. (2004) Designing novel spectral classes of proteins with a

tryptophan-expanded genetic code, Biol. Chem. 385, 893-904.

48. Taki, M., Hohsaka, T., Murakami, H., Kuno, A., Hasegawa, T., Taira, K., and Sisido, M.

(2002) A novel fluorescent nonnatural amino acid that can be incorporated into a

specific position of streptavidin, Nucleic Acids Res. Suppl., 203-204.

49. Hohsaka, T., and Sisido, M. (2002) Incorporation of non-natural amino acids into

proteins, Curr. Opin. Chem. Biol. 6, 809-815.

Page 139: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

122

50. Taki, M., Hohsaka, T., Murakami, H., Taira, K., and Sisido, M. (2002) Position-specific

incorporation of a fluorophore-quencher pair into a single streptavidin through

orthogonal four-base codon/anticodon pairs, J. Am. Chem. Soc. 124, 14586-14590.

51. Link, A. J., Mock, M. L., and Tirrell, D. A. (2003) Non-canonical amino acids in protein

engineering, Curr. Opin. Biotech. 14, 603-609.

52. Wang, L., and Schultz, P. G. (2005) Expanding the genetic code, Angew. Chem. Int.

Ed. Engl. 44, 34-66.

53. Furter, R. (1998) Expansion of the genetic code: Site-directed p-fluoro-phenylalanine

incorporation in Escherichia coli, Protein Sci. 7, 419-426.

54. Drabkin, H. J., Park, H. J., and RajBhandary, U. L. (1996) Amber suppression in

mammalian cells dependent upon expression of an Escherichia coli aminoacyl-tRNA

synthetase gene, Mol. Cell. Biol. 16, 907-913.

55. Anderson, J. C., Wu, N., Santoro, S. W., Lakshman, V., King, D. S., and Schultz, P. G.

(2004) An expanded genetic code with a functional quadruplet codon, Proc. Natl. Acad.

Sci. U.S.A. 101, 7566-7571.

56. Xie, J. M., and Schultz, P. G. (2005) Adding amino acids to the genetic repertoire, Curr.

Opin. Chem. Biol. 9, 548-554.

57. Anderson, J. C., and Schultz, P. G. (2003) Adaptation of an orthogonal archaeal leucyl-

tRNA and synthetase pair for four-base, amber, and opal suppression, Biochemistry 42,

9598-9608.

58. Santoro, S. W., Anderson, J. C., Lakshman, V., and Schultz, P. G. (2003) An

archaebacteria-derived glutamyl-tRNA synthetase and tRNA pair for unnatural amino

acid mutagenesis of proteins in Escherichia coli, Nuc. Acids Res. 31, 6700-6709.

59. Chin, J. W., Cropp, T. A., Anderson, J. C., Mukherji, M., Zhang, Z. W., and Schultz, P.

G. (2003) An expanded eukaryotic genetic code, Science 301, 964-967.

60. Chin, J. W., Cropp, T. A., Chu, S., Meggers, E., and Schultz, P. G. (2003) Progress

toward an expanded eukaryotic genetic code, Chem. Biol. 10, 511-519.

61. Beene, D. L., Dougherty, D. A., and Lester, H. A. (2003) Unnatural amino acid

mutagenesis in mapping ion channel function, Curr. Opin. Neurobiol. 13, 264-270.

62. Dougherty, D. A. (2000) Unnatural amino acids as probes of protein structure and

function, Curr. Opin. Chem. Biol. 4, 645-652.

Page 140: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

123

63. Rodriguez, E. A., Lester, H. A., and Dougherty, D. A. (2006) In vivo incorporation of

multiple unnatural amino acids through nonsense and frameshift suppression, Proc.

Natl. Acad. Sci. U.S.A. 103, 8650-8655.

64. Taki, M., Hohsaka, T., Murakami, H., Taira, K., and Sisido, M. (2001) A non-natural

amino acid for efficient incorporation into proteins as a sensitive fluorescent probe,

FEBS Lett. 507, 35-38.

65. Hohsaka, T., Kajihara, D., Ashizuka, Y., Murakami, H., and Sisido, M. (1999) Efficient

incorporation of nonnatural amino acids with large aromatic groups into streptavidin in

in vitro protein synthesizing systems, J. Am. Chem. Soc. 121, 34-40.

66. Anderson, J. C., Magliery, T. J., and Schultz, P. G. (2002) Exploring the limits of codon

and anticodon size, Chem. Biol. 9, 237-244.

67. Hohsaka, T., Ashizuka, Y., Murakami, H., and Sisido, M. (2001) Five-base codons for

incorporation of nonnatural amino acids into proteins, Nuc. Acids Res. 29, 3646-3651.

68. Kwon, I., Kirshenbaum, K., and Tirrell, D. A. (2003) Breaking the degeneracy of the

genetic code, J. Am. Chem. Soc. 125, 7512-7513.

69. Ibba, M., and Soll, D. (2000) Aminoacyl-tRNA synthesis, Annual Review of

Biochemistry 69, 617-650.

70. Ibba, M., Kast, P., and Hennecke, H. (1994) Substrate-Specificity Is Determined by

Amino-Acid Binding Pocket Size in Escherichia-Coli Phenylalanyl-Transfer-Rna

Synthetase, Biochemistry 33, 7107-7112.

71. Wollenberger, U., Spricigo, R., Leimkuhler, S., and Schroder, K. (2008) Protein

electrodes with direct electrochemical communication, Adv. Biochem. Eng. Biotechnol.

109, 19-64.

72. Karyakin, A. A. (2012) Principles of direct (mediator free) bioelectrocatalysis,

Bioelectrochemistry 88, 70-75.

73. D'Souza, F., Rogers, L. M., O'Dell, E. S., Kochman, A., and Kutner, W. (2005)

Immobilization and electrochemical redox behavior of cytochrome c on fullerene film-

modified electrodes, Bioelectrochemistry 66, 35-40.

74. Betso, S. R., Klapper, M. H., and Anderson, L. B. (1972) Electrochemical studies of

heme proteins. Coulometric, polarographic, and combined spectroelectrochemical

methods for reduction of the heme prosthetic group in cytochrome c, J. Am. Chem. Soc.

94, 8197-8204.

Page 141: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

124

75. Yeh, P., and Kuwana, T. (1977) Reversible Electrode-Reaction of Cytochrome-C,

Chem. Lett., 1145-1148.

76. Demontellano, P. R. O. (1992) Catalytic Sites of Hemoprotein Peroxidases, Annu. Rev.

Pharmacol. 32, 89-107.

77. Atamna, H., and Boyle, K. (2006) Amyloid-beta peptide binds with heme to form a

peroxidase: relationship to the cytopathologies of Alzheimer's disease, Proc. Natl. Acad.

Sci. U.S.A. 103, 3381-3386.

78. Karthikeyan, M., Jayakumar, V., Radhika, K., Bhaskaran, R., Velazhahan, R., and Alice,

D. (2005) Induction of resistance in host against the infection of leaf blight pathogen

(Alternaria palandui) in onion (Allium cepa var aggregatum), Indian J. Biochem.

Biophys. 42, 371-377.

79. Dawson, J. H. (1988) Probing structure-function relations in heme-containing

oxygenases and peroxidases, Science 240, 433-439.

80. Sono, M., Roach, M. P., Coulter, E. D., and Dawson, J. H. (1996) Heme-containing

oxygenases, Chem. Rev. 96, 2841-2887.

81. Schlichting, I., Berendzen, J., Chu, K., Stock, A. M., Maves, S. A., Benson, D. E.,

Sweet, B. M., Ringe, D., Petsko, G. A., and Sligar, S. G. (2000) The catalytic pathway

of cytochrome P450cam at atomic resolution, Science 287, 1615-1622.

82. Gerber, N. C., and Sligar, S. G. (1992) Catalytic Mechanism of Cytochrome-P-450 -

Evidence for a Distal Charge Relay, J. Am. Chem. Soc. 114, 8742-8743.

83. Gerber, N. C., and Sligar, S. G. (1994) A Role for Asp-251 in Cytochrome P-450cam

Oxygen Activation, J. Biol. Chem. 269, 4260-4266.

84. Vidakovic, M., Sligar, S. G., Li, H. Y., and Poulos, T. L. (1998) Understanding the role of

the essential Asp251 in cytochrome P450cam using site-directed mutagenesis,

crystallography, and kinetic solvent isotope effect, Biochemistry 37, 9211-9219.

85. Sitter, A. J., Reczek, C. M., and Terner, J. (1985) Heme-Linked Ionization of

Horseradish-Peroxidase Compound-Ii Monitored by the Resonance Raman Fe(Iv)=O

Stretching Vibration, J. Biol. Chem. 260, 7515-7522.

86. Gajhede, M., Schuller, D. J., Henriksen, A., Smith, A. T., and Poulos, T. L. (1997)

Crystal structure of horseradish peroxidase C at 2.15 angstrom resolution, Nat. Struct.

Biol. 4, 1032-1038.

Page 142: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

125

87. Roach, M. P., Chen, Y. P., Woodin, S. A., Lincoln, D. E., Lovell, C. R., and Dawson, J.

H. (1997) Notomastus lobatus chloroperoxidase and Amphitrite ornata

dehaloperoxidase both contain histidine as their proximal heme iron ligand,

Biochemistry 36, 2197-2202.

88. Poulos, T. L. (1988) Heme Enzyme Crystal-Structures, Adv. Inorg. Biochem. 7, 1-36.

89. Poulos, T. L., Finzel, B. C., Gunsalus, I. C., Wagner, G. C., and Kraut, J. (1985) The

2.6-A crystal structure of Pseudomonas putida cytochrome P-450, J. Biol. Chem. 260,

16122-16130.

90. Watanabe, Y., Nakajima, H., and Ueno, T. (2007) Reactivities of oxo and peroxo

intermediates studied by hemoprotein mutants, Acc. Chem. Res. 40, 554-562.

91. Perera, R., Sono, M., Raner, G. M., and Dawson, J. H. (2005) Subzero-temperature

stabilization and spectroscopic characterization of homogeneous oxyferrous complexes

of the cytochrome P450BM3 (CYP102) oxygenase domain and holoenzyme, Biochem.

Bioph. Res. 338, 365-371.

92. Alfonta, L., Zhang, Z., Uryu, S., Loo, J. A., and Schultz, P. G. (2003) Site-specific

incorporation of a redox-active amino acid into proteins, J. Am. Chem. Soc. 125, 14662-

14663.

93. Magliery, T. J., Anderson, J. C., and Schultz, P. G. (2001) Expanding the genetic code:

Selection of efficient suppressors of four-base codons and identification of "shifty" four-

base codons with a library approach in Escherichia coli, J. Mol. Biol. 307, 755-769.

94. Park, H. S., Hohn, M. J., Umehara, T., Guo, L. T., Osborne, E. M., Benner, J., Noren, C.

J., Rinehart, J., and Soll, D. (2011) Expanding the Genetic Code of Escherichia coli with

Phosphoserine, Science 333, 1151-1154.

95. Seyedsayamdost, M. R., Xie, J., Chan, C. T. Y., Schultz, P. G., and Stubbe, J. (2007)

Site-specific insertion of 3-aminotyrosine into subunit alpha 2 of E-coli ribonucleotide

reductase: Direct evidence for involvement of Y-730 and Y-731 in radical propagation,

J. Am. Chem. Soc. 129, 15060-15071.

96. Paul, K. G., Theorell, H., Akeson, A. (1953) The Molar Light Absorption of Pyridine

Ferroprotoporphyrin, Acta. Chem. Scand. 1284-1287.

97. Ozaki, S., and Demontellano, P. R. O. (1995) Molecular Engineering of Horseradish-

Peroxidase - Thioether Sulfoxidation and Styrene Epoxidation by Phe-41 Leucine and

Threonine Mutants, J. Am. Chem. Soc. 117, 7056-7064.

Page 143: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

126

98. King, N. K., and Winfield, M. E. (1963) The mechanism of metmyoglobin oxidation, J.

Biol. Chem. 238, 1520-1528.

99. Ozaki, S., and Ishikawa, Y. (2006) One- and two-electron oxidation by the GLY-65 to

threonine myoglobin mutant, React. Kinet. Catal. Lett. 89, 21-28.

100. Carlsen, C. U., and Skibsted, L. H. (2004) Myoglobin species with enhanced

prooxidative activity is formed during mild proteolysis by pepsin, J. Agric. Food. Chem.

52, 1675-1681.

101. Carlsen, C. U., Skovgaard, I. M., and Skibsted, L. H. (2003) Pseudoperoxidase activity

of myoglobin: kinetics and mechanism of the peroxidase cycle of myoglobin with H2O2

and 2,2-azino-bis(3-ethylbenzthiazoline-6-sulfonate) as substrates, J. Agric. Food.

Chem. 51, 5815-5823.

102. Iwagami, S. G., Creagh, A. L., Haynes, C. A., Borsari, M., Felli, I. C., Piccioli, M., and

Eltis, L. D. (1995) The Role of a Conserved Tyrosine Residue in High-Potential Iron-

Sulfur Proteins, Protein Sci. 4, 2562-2572.

103. Sarma, S., DiGate, R. J., Goodin, D. B., Miller, C. J., and Guiles, R. D. (1997) Effect of

axial ligand plane reorientation on electronic and electrochemical properties observed in

the A67V mutant of rat cytochrome b(5), Biochemistry 36, 5658-5668.

104. Zemojtel, T., Rini, M., Heyne, K., Dandekar, T., Nibbering, E. T. J., and Kozlowski, P.

M. (2004) NO-bound myoglobin: Structural diversity and dynamics of the NO ligand, J.

Am. Chem. Soc. 126, 1930-1931.

105. Schoenbo.Bp, Watson, H. C., and Kendrew, J. C. (1965) Binding of Xenon to Sperm

Whale Myoglobin, Nature 207, 28-&.

106. Sundaramoorthy, M., Kishi, K., Gold, M. H., and Poulos, T. L. (1994) The crystal

structure of manganese peroxidase from Phanerochaete chrysosporium at 2.06-A

resolution, J. Biol. Chem. 269, 32759-32767.

107. Kunishima, N., Amada, F., Fukuyama, K., Kawamoto, M., Matsunaga, T., and

Matsubara, H. (1996) Pentacoordination of the heme iron of Arthromyces ramosus

peroxidase shown by a 1.8 A resolution crystallographic study at pH 4.5, FEBS Lett

378, 291-294.

108. Finzel, B. C., Poulos, T. L., and Kraut, J. (1984) Crystal structure of yeast cytochrome c

peroxidase refined at 1.7-A resolution, J. Biol. Chem. 259, 13027-13036.

Page 144: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

127

109. Springer, B. A., and Sligar, S. G. (1987) High-level expression of sperm whale

myoglobin in Escherichia coli, Proc. Natl. Acad. Sci. U. S. A. 84, 8961-8965.

110. Phillips, G. N., Jr., Arduini, R. M., Springer, B. A., and Sligar, S. G. (1990) Crystal

structure of myoglobin from a synthetic gene, Proteins 7, 358-365.

111. Quillin, M. L., Arduini, R. M., Olson, J. S., and Phillips, G. N., Jr. (1993) High-resolution

crystal structures of distal histidine mutants of sperm whale myoglobin, J. Mol. Biol.

234, 140-155.

112. Matsui, T., Nagano, S., Ishimori, K., Watanabe, Y., and Morishima, I. (1996)

Preparation and reactions of myoglobin mutants bearing both proximal cysteine ligand

and hydrophobic distal cavity: protein models for the active site of P-450, Biochemistry

35, 13118-13124.

113. Edwards, S. L., Raag, R., Wariishi, H., Gold, M. H., and Poulos, T. L. (1993) Crystal

structure of lignin peroxidase, Proc. Natl. Acad. Sci. U. S. A. 90, 750-754.

114. Poulos, T. L., Freer, S. T., Alden, R. A., Edwards, S. L., Skogland, U., Takio, K.,

Eriksson, B., Xuong, N., Yonetani, T., and Kraut, J. (1980) The crystal structure of

cytochrome c peroxidase, J. Biol. Chem. 255, 575-580.

115. Patterson, W. R., and Poulos, T. L. (1995) Crystal structure of recombinant pea

cytosolic ascorbate peroxidase, Biochemistry 34, 4331-4341.

116. Matsui, T., Ozaki, S., Liong, E., Phillips, G. N., Jr., and Watanabe, Y. (1999) Effects of

the location of distal histidine in the reaction of myoglobin with hydrogen peroxide, J.

Biol. Chem. 274, 2838-2844.

117. Takano, T. (1977) Structure of myoglobin refined at 2-0 A resolution. I. Crystallographic

refinement of metmyoglobin from sperm whale, J. Mol. Biol. 110, 537-568.

118. Sono, M., Perera, R., Jin, S., Makris, T. M., Sligar, S. G., Bryson, T. A., and Dawson, J.

H. (2005) The influence of substrate on the spectral properties of oxyferrous wild-type

and T252A cytochrome P450-CAM, Arch. Biochem. Biophys. 436, 40-49.

119. Montgomery, C. D. (2007) pi Backbonding in carbonyl complexes and carbon-oxygen

stretching frequencies: A molecular modeling exercise, J. Chem. Educ. 84, 102-105.

120. Kimmich, N., Das, A., Sevrioukova, I., Meharenna, Y., Sligar, S. G., and Poulos, T. L.

(2007) Electron transfer between cytochrome P450cin and its FMN-containing redox

partner, cindoxin, J. Biol. Chem. 282, 27006-27011.

Page 145: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

128

121. Hiner, A. N. P., Raven, E. L., Thorneley, R. N. F., Garcia-Canovas, F., and Rodriguez-

Lopez, J. N. (2002) Mechanisms of compound I formation in heme peroxidases, J.

Inorg. Biochem. 91, 27-34.

122. Yonetani, T., and Schleyer, H. (1967) Studies on cytochrome c peroxidase. IX. The

reaction of ferrimyoglobin with hydroperoxides and a comparison of peroxide-induced

compounds of ferrimyoglobin and cytochrome c peroxidase, J. Biol. Chem. 242, 1974-

1979.

123. Mukherjee, S., Sengupta, K., Das, M. R., Jana, S. S., and Dey, A. (2012) Site-specific

covalent attachment of heme proteins on self-assembled monolayers, J. Biol. Inorg.

Chem. 17, 1009-1023.

124. Liu, S. Q., and Ju, H. X. (2003) Electrocatalysis via direct electrochemistry of myoglobin

immobilized on colloidal gold nanoparticles, Electroanalysis 15, 1488-1493.

125. Rusling, J. F. (1998) Enzyme bioelectrochemistry in cast biomembrane-like films, Acc.

Chem. Res. 31, 363-369.

126. Armstrong, F. A., Hill, H. A. O., and Walton, N. J. (1988) Direct Electrochemistry of

Redox Proteins, Acc. Chem. Res. 21, 407-413.

127. Yarman, A., Nagel, T., Gajovic-Eichelmann, N., Fischer, A., Wollenberger, U., and

Scheller, F. W. (2011) Bioelectrocatalysis by Microperoxidase-11 in a Multilayer

Architecture of Chitosan Embedded Gold Nanoparticles, Electroanalysis 23, 611-618.

128. Moyo, M., Okonkwo, J. O., and Agyei, N. M. (2012) Recent Advances in Polymeric

Materials Used as Electron Mediators and Immobilizing Matrices in Developing Enzyme

Electrodes, Sensors 12, 923-953.

129. Hill, H. A. O. (1983) The Exploitation of the Electrochemistry of Proteins, Biochem. Soc.

Trans. 11, 453-455.

130. Krzeminski, L., Cronin, S., Ndamba, L., Canters, G. W., Aartsma, T. J., Evans, S. D.,

and Jeuken, L. J. C. (2011) Orientational Control over Nitrite Reductase on Modified

Gold Electrode and Its Effects on the Interfacial Electron Transfer, J. Phys. Chem. B

115, 12607-12614.

131. Uygun, A., Oksuz, L., Chowdhury, S., and Bhethanabotla, V. (2010) Fluorescence study

of protein immobilization on poly(4-hydroxyphenyl thiophene-3-carboxylate)-coated

electrodes, Mater Sci Eng C Mater Biol Appl 30, 868-872.

Page 146: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

129

132. Gates, A. J., Kemp, G. L., To, C. Y., Mann, J., Marritt, S. J., Mayes, A. G., Richardson,

D. J., and Butt, J. N. (2011) The relationship between redox enzyme activity and

electrochemical potential-cellular and mechanistic implications from protein film

electrochemistry, Phys. Chem. Chem. Phys. 13, 7720-7731.

133. Rusling, J. F., and Forster, R. J. (2003) Electrochemical catalysis with redox polymer

and polyion-protein films, J. Colloid Interface Sci. 262, 1-15.

134. Babaei, A., Garrett, D. J., and Downard, A. J. (2012) Electrochemical Investigations on

a Third Generation Biosensor for Determination of Hydrogen Peroxide Based on

Immobilization of Myoglobin on a Novel Platinum Nanoparticle/Carbon Nanotube/Ionic

Liquid/Nafion Composite, Int. J. Electrochem. Sc. 7, 3141-3154.

135. Loget, G., Chevance, S., Poriel, C., Simonneaux, G., Lagrost, C., and Rault-Berthelot,

J. (2011) Direct Electron Transfer of Hemoglobin and Myoglobin at the Bare Glassy

Carbon Electrode in an Aqueous BMI.BF4 Ionic-Liquid Mixture, Chemphyschem. 12,

411-418.

136. Choi, O., Kim, B. C., An, J. H., Min, K., Kim, Y. H., Um, Y., Oh, M. K., and Sang, B. I.

(2011) A biosensor based on the self-entrapment of glucose oxidase within biomimetic

silica nanoparticles induced by a fusion enzyme, Enzyme Microb. Technol. 49, 441-445.

137. You, C. P., Yan, X. W., Kong, J. L., Zhao, D. Y., and Liu, B. H. (2008) Direct

electrochemistry of myoglobin based on bicontinuous gyroidal mesoporous carbon

matrix, Electrochem. Commun. 10, 1864-1867.

138. Ferri, T., Poscia, A., and Santucci, R. (1998) Direct electrochemistry of membrane-

entrapped horseradish peroxidase. Part I. A voltammetric and spectroscopic study,

Bioelectroch. Bioener 44, 177-181.

139. Chen, L. F., Xie, H. Q., and Li, J. (2012) Electrochemical glucose biosensor based on

silver nanoparticles/multiwalled carbon nanotubes modified electrode, J. Solid State

Electrochem. 16, 3323-3329.

140. Zhang, F., Wu, J., and Zhang, H. B. (2012) Construction of hyaluronan-silver

nanoparticle-hemoglobin multilayer composite film and investigations on its

electrocatalytic properties, J. Solid State Electrochem. 16, 1683-1692.

141. Wang, X. H., Han, M., Bao, J. C., Tu, W. W., and Dai, Z. H. (2012) A superoxide anion

biosensor based on direct electron transfer of superoxide dismutase on sodium alginate

Page 147: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

130

sol-gel film and its application to monitoring of living cells, Analytica. Chimica. Acta.

717, 61-66.

142. Nadzhafova, O., Etienne, M., and Walcarius, A. (2007) Direct electrochemistry of

hemoglobin and glucose oxidase in electrodeposited sol-gel silica thin films on glassy

carbon, Electrochem. Commun. 9, 1189-1195.

143. Chen, H. J., and Dong, S. J. (2007) Direct electrochemistry and electrocatalysis of

horseradish peroxidase immobilized in sol-gel-derived ceramic-carbon nanotube

nanocomposite film, Biosens. Bioelectron. 22, 1811-1815.

144. Ran, Q., Peng, R., Liang, C., Ye, S. Q., Xian, Y. Z., Zhang, W. J., and Jin, L. T. (2011)

Covalent immobilization of horseradish peroxidase via click chemistry and its direct

electrochemistry, Talanta 83, 1381-1385.

145. Mazzei, F., Favero, G., Frasconi, M., Tata, A., and Pepi, F. (2009) Electron-Transfer

Kinetics of Microperoxidase-11 Covalently Immobilised onto the Surface of Multi-Walled

Carbon Nanotubes by Reactive Landing of Mass-Selected Ions, Chem.Eur. J. 15, 7359-

7367.

146. Albrecht, T., Li, W. W., Ulstrup, J., Haehnel, W., and Hildebrandt, P. (2005)

Electrochemical and spectroscopic investigations of immobilized de novo designed

heme proteins on metal electrodes, Chemphyschem. 6, 961-970.

147. Berg, J. M., Tymoczko, J. L., and Stryer, L. (2006) in Biochemistry, 6th ed., pp 491-550,

Freeman, New York.

148. Ozaki, S., Matsui, T., and Watanabe, Y. (1996) Conversion of myoglobin into a highly

stereospecific peroxygenase by the L29H/H64L mutation, J. Am. Chem. Soc. 118,

9784-9785.

149. Lvov, Y. M., Lu, Z. Q., Schenkman, J. B., Zu, X. L., and Rusling, J. F. (1998) Direct

electrochemistry of myoglobin and cytochrome p450(cam) in alternate layer-by-layer

films with DNA and other polyions, J. Am. Chem. Soc. 120, 4073-4080.

150. Kamau, G. N., Guto, M. P., Munge, B., Panchagnula, V., and Rusling, J. F. (2003)

Myoglobin coadsorbed on electrodes from microemulsions provides reversible

electrochemistry and tunable electrochemical catalysis, Langmuir 19, 6976-6981.

151. Paulo, T. D., Diogenes, I. C. N., and Abruna, H. D. (2011) Direct Electrochemistry and

Electrocatalysis of Myoglobin Immobilized on L-Cysteine Self-Assembled Gold

Electrode, Langmuir 27, 2052-2057.

Page 148: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

131

152. Zhang, J. D., and Oyama, M. (2005) Gold nanoparticle-attached ITO as a biocompatible

matrix for myoglobin immobilization: direct electrochemistry and catalysis to hydrogen

peroxide, J. Electroanal. Chem. 577, 273-279.

153. Schultz, K. C., Supekova, L., Ryu, Y., Xie, J., Perera, R., and Schultz, P. G. (2006) A

genetically encoded infrared probe, J. Am. Chem. Soc. 128, 13984-13985.

154. Seyedsayamdost, M. R., Xie, J., Chan, C. T., Schultz, P. G., and Stubbe, J. (2007) Site-

specific insertion of 3-aminotyrosine into subunit alpha2 of E. coli ribonucleotide

reductase: direct evidence for involvement of Y730 and Y731 in radical propagation, J.

Am. Chem. Soc. 129, 15060-15071.

155. Stamos, B., Loredo, L., Chand, S., Phan, T. V., Zhang, Y. B., Mohapatra, S.,

Rajeshwar, K., and Perera, R. (2012) Biosynthetic approach for functional protein

microarrays, Anal. Biochem. 424, 114-123.

156. de Groot, M. T., Merkx, M., and Koper, M. T. M. (2005) Heme release in myoglobin-

DDAB films and its role in electrochemical NO reduction, J. Am. Chem. Soc. 127,

16224-16232.

157. de Groot, M. T., Merkx, M., and Koper, M. T. M. (2006) Additional evidence for heme

release in myoglobin-DDAB films on pyrolitic graphite, Electrochem. Commun. 8, 999-

1004.

158. de Groot, M. T., Merkx, M., and Koper, M. T. M. (2007) Evidence for heme release in

layer-by-layer assemblies of myoglobin and polystyrenesulfonate on pyrolitic graphite,

J. Biol. Inorg. Chem. 12, 761-766.

159. Nakajima, N., and Ikada, Y. (1995) Mechanism of Amide Formation by Carbodiimide for

Bioconjugation in Aqueous-Media, Bioconjugate Chem. 6, 123-130.

160. Wang, L. W., Ran, Q., Tian, Y. A., Xu, J. J., Xian, Y. Z., Peng, R., and Jin, L. T. (2010)

Covalent immobilization of redox protein via click chemistry and carbodiimide reaction:

Direct electron transfer and biocatalysis, J. Colloid Interface Sci. 350, 544-550.

161. Bard, A. J., and Faulkner, L. R. (2001) Electrochemical Methods, Wiley, New York.

162. Zhang, H. M., and Li, N. Q. (2001) The direct electrochemistry of myoglobin at a DL-

homocysteine self-assembled gold electrode, Bioelectrochemistry 53, 97-101.

163. Xia, P. P., Liu, H. Q., and Tian, Y. (2009) Cathodic detection of H2O2 based on

nanopyramidal gold surface with enhanced electron transfer of myoglobin, Biosensors.

Bioelectron. 24, 2470-2474.

Page 149: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

132

164. Chai, H. M., Liu, H. Y., Guo, X. H., Zheng, D., Kutes, Y., Huey, B. D., Rusling, J. F., and

Hu, N. F. (2012) Long Distance Electron Transfer Across > 100 nm Thick Au

Nanoparticle/Polyion Films to a Surface Redox Protein, Electroanalysis 24, 1129-1140.

165. Xu, Y. X., Hu, C. G., and Hu, S. S. (2010) Electrochemical behavior of biocatalytical

composite based on heme-proteins, didodecyldimethylammonium bromide and room-

temperature ionic liquid, Analytica Chimica Acta 663, 19-26.

166. Mayo, S. L., Ellis, W. R., Jr., Crutchley, R. J., and Gray, H. B. (1986) Long-range

electron transfer in heme proteins, Science 233, 948-952.

167. Beier, M., and Hoheisel, J. D. (2004) Derivatization of glass and polypropylene

surfaces, Curr Protoc Nucleic Acid Chem. 12, Unit 12.4.

168. Rideout, D. C., and Breslow, R. (1980) Hydrophobic Acceleration of Diels-Alder

Reactions, J. Am. Chem. Soc. 102, 7816-7817.

169. Ordway, G. A., and Garry, D. J. (2004) Myoglobin: an essential hemoprotein in striated

muscle, J. Exp. Biol. 207, 3441-3446.

170. Collman, J. P., Boulatov, R., Sunderland, C. J., and Fu, L. (2004) Functional analogues

of cytochrome c oxidase, myoglobin, and hemoglobin, Chem. Rev. 104, 561-588.

171. Loew, G. H., and Harris, D. L. (2000) Role of the heme active site and protein

environment in structure, spectra, and function of the cytochrome p450s, Chem. Rev.

100, 407-419.

172. Anderson, J. L., and Chapman, S. K. (2005) Ligand probes for heme proteins, Dalton

Trans, 13-24.

173. Coulter, E. D., Sono, M., Chang, C. K., Lopez, O., and Dawson, J. H. (1995) Electron

paramagnetic resonance spectroscopy as a probe of coordination structure in green

heme systems: Iron chlorins and iron formylporphyrins reconstituted into myoglobin,

Inorg. Chim. Acta 240, 603-608.

174. Solomon, E. I. (2006) Spectroscopic methods in bioinorganic chemistry: Blue to green

to red copper sites, Inorg. Chem. 45, 8012-8025.

175. Roach, M. P., Pond, A. E., Thomas, M. R., Boxer, S. G., and Dawson, J. H. (1999) The

role of the distal and proximal protein environments in controlling the ferric spin state

and in stabilizing thiolate ligation in heme systems: Thiolate adducts of the myoglobin

H93G cavity mutant, J. Am. Chem. Soc. 121, 12088-12093.

Page 150: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

133

176. Olson, J. S., and Phillips, G. N. (1997) Myoglobin discriminates between O-2, NO, and

CO by electrostatic interactions with the bound ligand, J. Biol Inorg. Chem. 2, 544-552.

177. Maurus, R., Bogumil, R., Nguyen, N. T., Mauk, A. G., and Brayer, G. (1998) Structural

and spectroscopic studies of azide complexes of horse heart myoglobin and the His-64-

->Thr variant, Biochem. J. 332, 67-74.

Page 151: Genetically Modified Myoglobin As A Mimic For Heme Enzymes

134

BIOGRAPHICAL INFORMATION

Subhash Chand the elder son of Mr. Keshaw Prasad Yadav and Mrs. Urmila Devi

Yadav has obtained his high school education at Shri Shanker Ji Intermediate College,

Pushpanagar, Azamgarh. Ever since the initial years of education, his interests were focused in

subjects like Science and Mathematics. In his primary school days, he has been academically

oriented, always stood out for his scholastic performance and earned his way into the top rank

in his class. He received B.Sc. (Biology) degree from the Ewing Christian College, Allahabad,

India and then M.Sc. (Botany) degree from University of Allahabad, Allahabad, India. His

respectable educational credentials landed him in the Indian Institute of Technology, Kharagpur

(IIT Kharagpur), the prestigious science and technology institute of India, to pursue Master of

Technology in Applied Botany (Biotechnology). After receiving his Masters degree he joined

Meerut Institute of Engineering and Technology and served as Lecturer in Department of

Biotechnology and Applied Sciences. He soon realized that higher education plays an important

role in advancing one’s professional life and moved to USA to join University of Texas at

Arlington so as carry out doctoral research. He joined Dr. Roshan Perera’s group to obtain his

Doctoral degree in Biochemistry. There he conducted stimulating research to incorporate

unnatural amino acids in genetically modified myoglobin mutants so as to mimic the catalytic

activities of various heme proteins.